#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Multimodal neuroimaging evidence for looser lexico-semantic networks in schizophrenia: Evidence from masked indirect semantic priming It has been hypothesized that schizophrenia is characterized by overly broad automatic activity within lexico-semantic networks.
1-1	0-10	Multimodal	_
1-2	11-23	neuroimaging	_
1-3	24-32	evidence	_
1-4	33-36	for	_
1-5	37-43	looser	_
1-6	44-59	lexico-semantic	_
1-7	60-68	networks	_
1-8	69-71	in	_
1-9	72-85	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-10	86-87	:	_
1-11	88-96	Evidence	_
1-12	97-101	from	_
1-13	102-108	masked	_
1-14	109-117	indirect	_
1-15	118-126	semantic	_
1-16	127-134	priming	_
1-17	135-137	It	_
1-18	138-141	has	_
1-19	142-146	been	_
1-20	147-159	hypothesized	_
1-21	160-164	that	_
1-22	165-178	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-23	179-181	is	_
1-24	182-195	characterized	_
1-25	196-198	by	_
1-26	199-205	overly	_
1-27	206-211	broad	_
1-28	212-221	automatic	_
1-29	222-230	activity	_
1-30	231-237	within	_
1-31	238-253	lexico-semantic	_
1-32	254-262	networks	_
1-33	263-264	.	_

Text=We used two complementary neuroimaging techniques, Magnetoencephalography (MEG) and functional Magnetic Resonance Imaging (fMRI), in combination with a highly automatic indirect semantic priming paradigm, to spatiotemporally localize this abnormality in the brain.
2-1	265-267	We	_
2-2	268-272	used	_
2-3	273-276	two	_
2-4	277-290	complementary	_
2-5	291-303	neuroimaging	_
2-6	304-314	techniques	_
2-7	315-316	,	_
2-8	317-339	Magnetoencephalography	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
2-9	340-341	(	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
2-10	342-345	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
2-11	346-347	)	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
2-12	348-351	and	_
2-13	352-362	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-14	363-371	Magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-15	372-381	Resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-16	382-389	Imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-17	390-391	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-18	392-396	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-19	397-398	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-20	399-400	,	_
2-21	401-403	in	_
2-22	404-415	combination	_
2-23	416-420	with	_
2-24	421-422	a	_
2-25	423-429	highly	_
2-26	430-439	automatic	_
2-27	440-448	indirect	_
2-28	449-457	semantic	_
2-29	458-465	priming	_
2-30	466-474	paradigm	_
2-31	475-476	,	_
2-32	477-479	to	_
2-33	480-496	spatiotemporally	_
2-34	497-505	localize	_
2-35	506-510	this	_
2-36	511-522	abnormality	_
2-37	523-525	in	_
2-38	526-529	the	_
2-39	530-535	brain	_
2-40	536-537	.	_

Text=Eighteen people with schizophrenia and 20 demographically-matched control participants viewed target words (“ bell ”) preceded by directly related (“ church ”), indirectly related (“ priest ”), or unrelated (“ hammer ”) prime words in MEG and fMRI sessions.
3-1	538-546	Eighteen	_
3-2	547-553	people	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-3	554-558	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-4	559-572	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-5	573-576	and	_
3-6	577-579	20	_
3-7	580-603	demographically-matched	_
3-8	604-611	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
3-9	612-624	participants	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
3-10	625-631	viewed	_
3-11	632-638	target	_
3-12	639-644	words	_
3-13	645-646	(	_
3-14	647-648	“	_
3-15	649-653	bell	_
3-16	654-655	”	_
3-17	656-657	)	_
3-18	658-666	preceded	_
3-19	667-669	by	_
3-20	670-678	directly	_
3-21	679-686	related	_
3-22	687-688	(	_
3-23	689-690	“	_
3-24	691-697	church	_
3-25	698-699	”	_
3-26	700-701	)	_
3-27	702-703	,	_
3-28	704-714	indirectly	_
3-29	715-722	related	_
3-30	723-724	(	_
3-31	725-726	“	_
3-32	727-733	priest	_
3-33	734-735	”	_
3-34	736-737	)	_
3-35	738-739	,	_
3-36	740-742	or	_
3-37	743-752	unrelated	_
3-38	753-754	(	_
3-39	755-756	“	_
3-40	757-763	hammer	_
3-41	764-765	”	_
3-42	766-767	)	_
3-43	768-773	prime	_
3-44	774-779	words	_
3-45	780-782	in	_
3-46	783-786	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
3-47	787-790	and	_
3-48	791-795	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-49	796-804	sessions	_
3-50	805-806	.	_

Text=To minimize top-down processing, the prime was masked, the target appeared only 140 ms after prime onset, and participants simply monitored for words within a particular semantic category that appeared in filler trials.
4-1	807-809	To	_
4-2	810-818	minimize	_
4-3	819-827	top-down	_
4-4	828-838	processing	_
4-5	839-840	,	_
4-6	841-844	the	_
4-7	845-850	prime	_
4-8	851-854	was	_
4-9	855-861	masked	_
4-10	862-863	,	_
4-11	864-867	the	_
4-12	868-874	target	_
4-13	875-883	appeared	_
4-14	884-888	only	_
4-15	889-892	140	_
4-16	893-895	ms	_
4-17	896-901	after	_
4-18	902-907	prime	_
4-19	908-913	onset	_
4-20	914-915	,	_
4-21	916-919	and	_
4-22	920-932	participants	_
4-23	933-939	simply	_
4-24	940-949	monitored	_
4-25	950-953	for	_
4-26	954-959	words	_
4-27	960-966	within	_
4-28	967-968	a	_
4-29	969-979	particular	_
4-30	980-988	semantic	_
4-31	989-997	category	_
4-32	998-1002	that	_
4-33	1003-1011	appeared	_
4-34	1012-1014	in	_
4-35	1015-1021	filler	_
4-36	1022-1028	trials	_
4-37	1029-1030	.	_

Text=Both techniques revealed a significantly larger automatic indirect priming effect in people with schizophrenia than in control participants.
5-1	1031-1035	Both	_
5-2	1036-1046	techniques	_
5-3	1047-1055	revealed	_
5-4	1056-1057	a	_
5-5	1058-1071	significantly	_
5-6	1072-1078	larger	_
5-7	1079-1088	automatic	_
5-8	1089-1097	indirect	_
5-9	1098-1105	priming	_
5-10	1106-1112	effect	_
5-11	1113-1115	in	_
5-12	1116-1122	people	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-13	1123-1127	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-14	1128-1141	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-15	1142-1146	than	_
5-16	1147-1149	in	_
5-17	1150-1157	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
5-18	1158-1170	participants	_
5-19	1171-1172	.	_

Text=MEG temporally localized this enhanced effect to the N400 time window (300–500 ms) — the critical stage of accessing meaning from words.
6-1	1173-1176	MEG	_
6-2	1177-1187	temporally	_
6-3	1188-1197	localized	_
6-4	1198-1202	this	_
6-5	1203-1211	enhanced	_
6-6	1212-1218	effect	_
6-7	1219-1221	to	_
6-8	1222-1225	the	_
6-9	1226-1230	N400	_
6-10	1231-1235	time	_
6-11	1236-1242	window	_
6-12	1243-1244	(	_
6-13	1245-1252	300–500	_
6-14	1253-1255	ms	_
6-15	1256-1257	)	_
6-16	1258-1259	—	_
6-17	1260-1263	the	_
6-18	1264-1272	critical	_
6-19	1273-1278	stage	_
6-20	1279-1281	of	_
6-21	1282-1291	accessing	_
6-22	1292-1299	meaning	_
6-23	1300-1304	from	_
6-24	1305-1310	words	_
6-25	1311-1312	.	_

Text=fMRI spatially localized the effect to the left temporal fusiform cortex, which plays a role in mapping of orthographic word-form on to meaning.
7-1	1313-1317	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
7-2	1318-1327	spatially	_
7-3	1328-1337	localized	_
7-4	1338-1341	the	_
7-5	1342-1348	effect	_
7-6	1349-1351	to	_
7-7	1352-1355	the	_
7-8	1356-1360	left	_
7-9	1361-1369	temporal	_
7-10	1370-1378	fusiform	_
7-11	1379-1385	cortex	_
7-12	1386-1387	,	_
7-13	1388-1393	which	_
7-14	1394-1399	plays	_
7-15	1400-1401	a	_
7-16	1402-1406	role	_
7-17	1407-1409	in	_
7-18	1410-1417	mapping	_
7-19	1418-1420	of	_
7-20	1421-1433	orthographic	_
7-21	1434-1443	word-form	_
7-22	1444-1446	on	_
7-23	1447-1449	to	_
7-24	1450-1457	meaning	_
7-25	1458-1459	.	_

Text=There was no evidence of an enhanced automatic direct semantic priming effect in the schizophrenia group.
8-1	1460-1465	There	_
8-2	1466-1469	was	_
8-3	1470-1472	no	_
8-4	1473-1481	evidence	_
8-5	1482-1484	of	_
8-6	1485-1487	an	_
8-7	1488-1496	enhanced	_
8-8	1497-1506	automatic	_
8-9	1507-1513	direct	_
8-10	1514-1522	semantic	_
8-11	1523-1530	priming	_
8-12	1531-1537	effect	_
8-13	1538-1540	in	_
8-14	1541-1544	the	_
8-15	1545-1558	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-16	1559-1564	group	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-17	1565-1566	.	_

Text=These findings provide converging neural evidence for abnormally broad highly automatic lexico-semantic activity in schizophrenia.
9-1	1567-1572	These	_
9-2	1573-1581	findings	_
9-3	1582-1589	provide	_
9-4	1590-1600	converging	_
9-5	1601-1607	neural	_
9-6	1608-1616	evidence	_
9-7	1617-1620	for	_
9-8	1621-1631	abnormally	_
9-9	1632-1637	broad	_
9-10	1638-1644	highly	_
9-11	1645-1654	automatic	_
9-12	1655-1670	lexico-semantic	_
9-13	1671-1679	activity	_
9-14	1680-1682	in	_
9-15	1683-1696	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-16	1697-1698	.	_

Text=We argue that, rather than arising from an unconstrained spread of automatic activation across semantic memory, this broader automatic lexico-semantic activity stems from looser mappings between the form and meaning of words.
10-1	1699-1701	We	_
10-2	1702-1707	argue	_
10-3	1708-1712	that	_
10-4	1713-1714	,	_
10-5	1715-1721	rather	_
10-6	1722-1726	than	_
10-7	1727-1734	arising	_
10-8	1735-1739	from	_
10-9	1740-1742	an	_
10-10	1743-1756	unconstrained	_
10-11	1757-1763	spread	_
10-12	1764-1766	of	_
10-13	1767-1776	automatic	_
10-14	1777-1787	activation	_
10-15	1788-1794	across	_
10-16	1795-1803	semantic	_
10-17	1804-1810	memory	_
10-18	1811-1812	,	_
10-19	1813-1817	this	_
10-20	1818-1825	broader	_
10-21	1826-1835	automatic	_
10-22	1836-1851	lexico-semantic	_
10-23	1852-1860	activity	_
10-24	1861-1866	stems	_
10-25	1867-1871	from	_
10-26	1872-1878	looser	_
10-27	1879-1887	mappings	_
10-28	1888-1895	between	_
10-29	1896-1899	the	_
10-30	1900-1904	form	_
10-31	1905-1908	and	_
10-32	1909-1916	meaning	_
10-33	1917-1919	of	_
10-34	1920-1925	words	_
10-35	1926-1927	.	_

Text=Methods Materials The stimulus materials have previously been described in detail.
11-1	1928-1935	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-2	1936-1945	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-3	1946-1949	The	_
11-4	1950-1958	stimulus	_
11-5	1959-1968	materials	_
11-6	1969-1973	have	_
11-7	1974-1984	previously	_
11-8	1985-1989	been	_
11-9	1990-1999	described	_
11-10	2000-2002	in	_
11-11	2003-2009	detail	_
11-12	2010-2011	.	_

Text=They constituted 192 unique targets (e.g.
12-1	2012-2016	They	_
12-2	2017-2028	constituted	_
12-3	2029-2032	192	_
12-4	2033-2039	unique	_
12-5	2040-2047	targets	_
12-6	2048-2049	(	_
12-7	2050-2053	e.g	_
12-8	2054-2055	.	_

Text=“ bell ”) paired with primes that were either directly related (e.g.
13-1	2056-2057	“	_
13-2	2058-2062	bell	_
13-3	2063-2064	”	_
13-4	2065-2066	)	_
13-5	2067-2073	paired	_
13-6	2074-2078	with	_
13-7	2079-2085	primes	_
13-8	2086-2090	that	_
13-9	2091-2095	were	_
13-10	2096-2102	either	_
13-11	2103-2111	directly	_
13-12	2112-2119	related	_
13-13	2120-2121	(	_
13-14	2122-2125	e.g	_
13-15	2126-2127	.	_

Text=“ church ”), indirectly related (e.g.
14-1	2128-2129	“	_
14-2	2130-2136	church	_
14-3	2137-2138	”	_
14-4	2139-2140	)	_
14-5	2141-2142	,	_
14-6	2143-2153	indirectly	_
14-7	2154-2161	related	_
14-8	2162-2163	(	_
14-9	2164-2167	e.g	_
14-10	2168-2169	.	_

Text=“ priest ”), or unrelated (e.g.
15-1	2170-2171	“	_
15-2	2172-2178	priest	_
15-3	2179-2180	”	_
15-4	2181-2182	)	_
15-5	2183-2184	,	_
15-6	2185-2187	or	_
15-7	2188-2197	unrelated	_
15-8	2198-2199	(	_
15-9	2200-2203	e.g	_
15-10	2204-2205	.	_

Text=“ hammer ”).
16-1	2206-2207	“	_
16-2	2208-2214	hammer	_
16-3	2215-2216	”	_
16-4	2217-2218	)	_
16-5	2219-2220	.	_

Text=As previously described, the primes of the indirectly related pairs did not share obvious categorical relationships or direct associations with their targets.
17-1	2221-2223	As	_
17-2	2224-2234	previously	_
17-3	2235-2244	described	_
17-4	2245-2246	,	_
17-5	2247-2250	the	_
17-6	2251-2257	primes	_
17-7	2258-2260	of	_
17-8	2261-2264	the	_
17-9	2265-2275	indirectly	_
17-10	2276-2283	related	_
17-11	2284-2289	pairs	_
17-12	2290-2293	did	_
17-13	2294-2297	not	_
17-14	2298-2303	share	_
17-15	2304-2311	obvious	_
17-16	2312-2323	categorical	_
17-17	2324-2337	relationships	_
17-18	2338-2340	or	_
17-19	2341-2347	direct	_
17-20	2348-2360	associations	_
17-21	2361-2365	with	_
17-22	2366-2371	their	_
17-23	2372-2379	targets	_
17-24	2380-2381	.	_

Text=However, they did share more global similarities with their targets than the unrelated word-pairs, as indexed by Latent Semantic Analysis (; see also), as well as by a norming study in which participants were explicitly asked to identify the unstated mediator word (described by, pages 553 and 556–557).
18-1	2382-2389	However	_
18-2	2390-2391	,	_
18-3	2392-2396	they	_
18-4	2397-2400	did	_
18-5	2401-2406	share	_
18-6	2407-2411	more	_
18-7	2412-2418	global	_
18-8	2419-2431	similarities	_
18-9	2432-2436	with	_
18-10	2437-2442	their	_
18-11	2443-2450	targets	_
18-12	2451-2455	than	_
18-13	2456-2459	the	_
18-14	2460-2469	unrelated	_
18-15	2470-2480	word-pairs	_
18-16	2481-2482	,	_
18-17	2483-2485	as	_
18-18	2486-2493	indexed	_
18-19	2494-2496	by	_
18-20	2497-2503	Latent	_
18-21	2504-2512	Semantic	_
18-22	2513-2521	Analysis	_
18-23	2522-2523	(	_
18-24	2524-2525	;	_
18-25	2526-2529	see	_
18-26	2530-2534	also	_
18-27	2535-2536	)	_
18-28	2537-2538	,	_
18-29	2539-2541	as	_
18-30	2542-2546	well	_
18-31	2547-2549	as	_
18-32	2550-2552	by	_
18-33	2553-2554	a	_
18-34	2555-2562	norming	_
18-35	2563-2568	study	_
18-36	2569-2571	in	_
18-37	2572-2577	which	_
18-38	2578-2590	participants	_
18-39	2591-2595	were	_
18-40	2596-2606	explicitly	_
18-41	2607-2612	asked	_
18-42	2613-2615	to	_
18-43	2616-2624	identify	_
18-44	2625-2628	the	_
18-45	2629-2637	unstated	_
18-46	2638-2646	mediator	_
18-47	2647-2651	word	_
18-48	2652-2653	(	_
18-49	2654-2663	described	_
18-50	2664-2666	by	_
18-51	2667-2668	,	_
18-52	2669-2674	pages	_
18-53	2675-2678	553	_
18-54	2679-2682	and	_
18-55	2683-2690	556–557	_
18-56	2691-2692	)	_
18-57	2693-2694	.	_

Text=The same targets were counterbalanced across three lists.
19-1	2695-2698	The	_
19-2	2699-2703	same	_
19-3	2704-2711	targets	_
19-4	2712-2716	were	_
19-5	2717-2732	counterbalanced	_
19-6	2733-2739	across	_
19-7	2740-2745	three	_
19-8	2746-2751	lists	_
19-9	2752-2753	.	_

Text=Each list contained 64 directly related pairs, 64 indirectly related pairs, and 64 unrelated pairs, in randomized order.
20-1	2754-2758	Each	_
20-2	2759-2763	list	_
20-3	2764-2773	contained	_
20-4	2774-2776	64	_
20-5	2777-2785	directly	_
20-6	2786-2793	related	_
20-7	2794-2799	pairs	_
20-8	2800-2801	,	_
20-9	2802-2804	64	_
20-10	2805-2815	indirectly	_
20-11	2816-2823	related	_
20-12	2824-2829	pairs	_
20-13	2830-2831	,	_
20-14	2832-2835	and	_
20-15	2836-2838	64	_
20-16	2839-2848	unrelated	_
20-17	2849-2854	pairs	_
20-18	2855-2856	,	_
20-19	2857-2859	in	_
20-20	2860-2870	randomized	_
20-21	2871-2876	order	_
20-22	2877-2878	.	_

Text=No prime or target word appeared twice in the same list, but across all participants, the same targets could appear in all three conditions.
21-1	2879-2881	No	_
21-2	2882-2887	prime	_
21-3	2888-2890	or	_
21-4	2891-2897	target	_
21-5	2898-2902	word	_
21-6	2903-2911	appeared	_
21-7	2912-2917	twice	_
21-8	2918-2920	in	_
21-9	2921-2924	the	_
21-10	2925-2929	same	_
21-11	2930-2934	list	_
21-12	2935-2936	,	_
21-13	2937-2940	but	_
21-14	2941-2947	across	_
21-15	2948-2951	all	_
21-16	2952-2964	participants	_
21-17	2965-2966	,	_
21-18	2967-2970	the	_
21-19	2971-2975	same	_
21-20	2976-2983	targets	_
21-21	2984-2989	could	_
21-22	2990-2996	appear	_
21-23	2997-2999	in	_
21-24	3000-3003	all	_
21-25	3004-3009	three	_
21-26	3010-3020	conditions	_
21-27	3021-3022	.	_

Text=Thus, differences between conditions could not be attributed to differences to the lexical properties of the targets or the primes.
22-1	3023-3027	Thus	_
22-2	3028-3029	,	_
22-3	3030-3041	differences	_
22-4	3042-3049	between	_
22-5	3050-3060	conditions	_
22-6	3061-3066	could	_
22-7	3067-3070	not	_
22-8	3071-3073	be	_
22-9	3074-3084	attributed	_
22-10	3085-3087	to	_
22-11	3088-3099	differences	_
22-12	3100-3102	to	_
22-13	3103-3106	the	_
22-14	3107-3114	lexical	_
22-15	3115-3125	properties	_
22-16	3126-3128	of	_
22-17	3129-3132	the	_
22-18	3133-3140	targets	_
22-19	3141-3143	or	_
22-20	3144-3147	the	_
22-21	3148-3154	primes	_
22-22	3155-3156	.	_

Text=Each list also contained 40 filler unrelated word-pairs in which either the prime (50%) or the target (50%) was the name of an insect.
23-1	3157-3161	Each	_
23-2	3162-3166	list	_
23-3	3167-3171	also	_
23-4	3172-3181	contained	_
23-5	3182-3184	40	_
23-6	3185-3191	filler	_
23-7	3192-3201	unrelated	_
23-8	3202-3212	word-pairs	_
23-9	3213-3215	in	_
23-10	3216-3221	which	_
23-11	3222-3228	either	_
23-12	3229-3232	the	_
23-13	3233-3238	prime	_
23-14	3239-3240	(	_
23-15	3241-3243	50	_
23-16	3244-3245	%	_
23-17	3246-3247	)	_
23-18	3248-3250	or	_
23-19	3251-3254	the	_
23-20	3255-3261	target	_
23-21	3262-3263	(	_
23-22	3264-3266	50	_
23-23	3267-3268	%	_
23-24	3269-3270	)	_
23-25	3271-3274	was	_
23-26	3275-3278	the	_
23-27	3279-3283	name	_
23-28	3284-3286	of	_
23-29	3287-3289	an	_
23-30	3290-3296	insect	_
23-31	3297-3298	.	_

Text=These were included for the purpose of the semantic monitoring task (described below).
24-1	3299-3304	These	_
24-2	3305-3309	were	_
24-3	3310-3318	included	_
24-4	3319-3322	for	_
24-5	3323-3326	the	_
24-6	3327-3334	purpose	_
24-7	3335-3337	of	_
24-8	3338-3341	the	_
24-9	3342-3350	semantic	_
24-10	3351-3361	monitoring	_
24-11	3362-3366	task	_
24-12	3367-3368	(	_
24-13	3369-3378	described	_
24-14	3379-3384	below	_
24-15	3385-3386	)	_
24-16	3387-3388	.	_

Text=Participants People with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder (confirmed with a Structured Clinical Interview, see) were recruited from the Lindemann Mental Health Center, Boston.
25-1	3389-3401	Participants	_
25-2	3402-3408	People	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-3	3409-3413	with	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-4	3414-3415	a	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-5	3416-3422	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-6	3423-3432	diagnosis	_
25-7	3433-3435	of	_
25-8	3436-3449	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
25-9	3450-3452	or	_
25-10	3453-3468	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
25-11	3469-3477	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarTypeSchizoaffectiveDisorder
25-12	3478-3479	(	_
25-13	3480-3489	confirmed	_
25-14	3490-3494	with	_
25-15	3495-3496	a	_
25-16	3497-3507	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-17	3508-3516	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-18	3517-3526	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
25-19	3527-3528	,	_
25-20	3529-3532	see	_
25-21	3533-3534	)	_
25-22	3535-3539	were	_
25-23	3540-3549	recruited	_
25-24	3550-3554	from	_
25-25	3555-3558	the	_
25-26	3559-3568	Lindemann	_
25-27	3569-3575	Mental	_
25-28	3576-3582	Health	_
25-29	3583-3589	Center	_
25-30	3590-3591	,	_
25-31	3592-3598	Boston	_
25-32	3599-3600	.	_

Text=Demographically matched volunteers without histories of psychiatric disorders were recruited by advertisement.
26-1	3601-3616	Demographically	_
26-2	3617-3624	matched	_
26-3	3625-3635	volunteers	_
26-4	3636-3643	without	_
26-5	3644-3653	histories	_
26-6	3654-3656	of	_
26-7	3657-3668	psychiatric	_
26-8	3669-3678	disorders	_
26-9	3679-3683	were	_
26-10	3684-3693	recruited	_
26-11	3694-3696	by	_
26-12	3697-3710	advertisement	_
26-13	3711-3712	.	_

Text=All participants were right-handed, as assessed using the Edinburgh handedness questionnaire, and were native, primarily monolingual American English speakers.
27-1	3713-3716	All	_
27-2	3717-3729	participants	_
27-3	3730-3734	were	_
27-4	3735-3747	right-handed	_
27-5	3748-3749	,	_
27-6	3750-3752	as	_
27-7	3753-3761	assessed	_
27-8	3762-3767	using	_
27-9	3768-3771	the	_
27-10	3772-3781	Edinburgh	_
27-11	3782-3792	handedness	_
27-12	3793-3806	questionnaire	_
27-13	3807-3808	,	_
27-14	3809-3812	and	_
27-15	3813-3817	were	_
27-16	3818-3824	native	_
27-17	3825-3826	,	_
27-18	3827-3836	primarily	_
27-19	3837-3848	monolingual	_
27-20	3849-3857	American	_
27-21	3858-3865	English	_
27-22	3866-3874	speakers	_
27-23	3875-3876	.	_

Text=Participants were excluded if they had a history of neurological injury, medical disorders impairing neurocognitive function, or if they met DSM-IV criteria for substance abuse (within three months) or substance dependence.
28-1	3877-3889	Participants	_
28-2	3890-3894	were	_
28-3	3895-3903	excluded	_
28-4	3904-3906	if	_
28-5	3907-3911	they	_
28-6	3912-3915	had	_
28-7	3916-3917	a	_
28-8	3918-3925	history	_
28-9	3926-3928	of	_
28-10	3929-3941	neurological	_
28-11	3942-3948	injury	_
28-12	3949-3950	,	_
28-13	3951-3958	medical	_
28-14	3959-3968	disorders	_
28-15	3969-3978	impairing	_
28-16	3979-3993	neurocognitive	_
28-17	3994-4002	function	_
28-18	4003-4004	,	_
28-19	4005-4007	or	_
28-20	4008-4010	if	_
28-21	4011-4015	they	_
28-22	4016-4019	met	_
28-23	4020-4026	DSM-IV	_
28-24	4027-4035	criteria	_
28-25	4036-4039	for	_
28-26	4040-4049	substance	_
28-27	4050-4055	abuse	_
28-28	4056-4057	(	_
28-29	4058-4064	within	_
28-30	4065-4070	three	_
28-31	4071-4077	months	_
28-32	4078-4079	)	_
28-33	4080-4082	or	_
28-34	4083-4092	substance	_
28-35	4093-4103	dependence	_
28-36	4104-4105	.	_

Text=Written consent was obtained following the guidelines of the Massachusetts General Hospital Human Subjects Research Committee.
29-1	4106-4113	Written	_
29-2	4114-4121	consent	_
29-3	4122-4125	was	_
29-4	4126-4134	obtained	_
29-5	4135-4144	following	_
29-6	4145-4148	the	_
29-7	4149-4159	guidelines	_
29-8	4160-4162	of	_
29-9	4163-4166	the	_
29-10	4167-4180	Massachusetts	_
29-11	4181-4188	General	_
29-12	4189-4197	Hospital	_
29-13	4198-4203	Human	_
29-14	4204-4212	Subjects	_
29-15	4213-4221	Research	_
29-16	4222-4231	Committee	_
29-17	4232-4233	.	_

Text=Most patients ’ symptoms were assessed on the day of either the fMRI or the MEG session using the Scale for the Assessment of Positive Symptoms (SAPS:), and the Scale for the Assessment of Negative Symptoms (SANS:).
30-1	4234-4238	Most	_
30-2	4239-4247	patients	_
30-3	4248-4249	’	_
30-4	4250-4258	symptoms	_
30-5	4259-4263	were	_
30-6	4264-4272	assessed	_
30-7	4273-4275	on	_
30-8	4276-4279	the	_
30-9	4280-4283	day	_
30-10	4284-4286	of	_
30-11	4287-4293	either	_
30-12	4294-4297	the	_
30-13	4298-4302	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
30-14	4303-4305	or	_
30-15	4306-4309	the	_
30-16	4310-4313	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
30-17	4314-4321	session	_
30-18	4322-4327	using	_
30-19	4328-4331	the	_
30-20	4332-4337	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-21	4338-4341	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-22	4342-4345	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-23	4346-4356	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-24	4357-4359	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-25	4360-4368	Positive	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-26	4369-4377	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-27	4378-4379	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
30-28	4380-4384	SAPS	_
30-29	4385-4386	:	_
30-30	4387-4388	)	_
30-31	4389-4390	,	_
30-32	4391-4394	and	_
30-33	4395-4398	the	_
30-34	4399-4404	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-35	4405-4408	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-36	4409-4412	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-37	4413-4423	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-38	4424-4426	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-39	4427-4435	Negative	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-40	4436-4444	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
30-41	4445-4446	(	_
30-42	4447-4451	SANS	_
30-43	4452-4453	:	_
30-44	4454-4455	)	_
30-45	4456-4457	.	_

Text=Our control dataset was n = 20 for fMRI and n = 18 for MEG.
31-1	4458-4461	Our	_
31-2	4462-4469	control	_
31-3	4470-4477	dataset	_
31-4	4478-4481	was	_
31-5	4482-4483	n	_
31-6	4484-4485	=	_
31-7	4486-4488	20	_
31-8	4489-4492	for	_
31-9	4493-4497	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
31-10	4498-4501	and	_
31-11	4502-4503	n	_
31-12	4504-4505	=	_
31-13	4506-4508	18	_
31-14	4509-4512	for	_
31-15	4513-4516	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
31-16	4517-4518	.	_

Text=Twenty-one control participants were originally recruited.
32-1	4519-4529	Twenty-one	_
32-2	4530-4537	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
32-3	4538-4550	participants	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
32-4	4551-4555	were	_
32-5	4556-4566	originally	_
32-6	4567-4576	recruited	_
32-7	4577-4578	.	_

Text=One was subsequently excluded because of a structural MRI abnormality, and two failed to return for the MEG session.
33-1	4579-4582	One	_
33-2	4583-4586	was	_
33-3	4587-4599	subsequently	_
33-4	4600-4608	excluded	_
33-5	4609-4616	because	_
33-6	4617-4619	of	_
33-7	4620-4621	a	_
33-8	4622-4632	structural	_
33-9	4633-4636	MRI	_
33-10	4637-4648	abnormality	_
33-11	4649-4650	,	_
33-12	4651-4654	and	_
33-13	4655-4658	two	_
33-14	4659-4665	failed	_
33-15	4666-4668	to	_
33-16	4669-4675	return	_
33-17	4676-4679	for	_
33-18	4680-4683	the	_
33-19	4684-4687	MEG	_
33-20	4688-4695	session	_
33-21	4696-4697	.	_

Text=Our schizophrenia dataset was n = 16 for fMRI and n = 18 for MEG.
34-1	4698-4701	Our	_
34-2	4702-4715	schizophrenia	_
34-3	4716-4723	dataset	_
34-4	4724-4727	was	_
34-5	4728-4729	n	_
34-6	4730-4731	=	_
34-7	4732-4734	16	_
34-8	4735-4738	for	_
34-9	4739-4743	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
34-10	4744-4747	and	_
34-11	4748-4749	n	_
34-12	4750-4751	=	_
34-13	4752-4754	18	_
34-14	4755-4758	for	_
34-15	4759-4762	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
34-16	4763-4764	.	_

Text=Twenty-two schizophrenia participants were originally recruited, but two were excluded from both fMRI and MEG analysis (technical problems and a failure to complete the fMRI study).
35-1	4765-4775	Twenty-two	_
35-2	4776-4789	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
35-3	4790-4802	participants	_
35-4	4803-4807	were	_
35-5	4808-4818	originally	_
35-6	4819-4828	recruited	_
35-7	4829-4830	,	_
35-8	4831-4834	but	_
35-9	4835-4838	two	_
35-10	4839-4843	were	_
35-11	4844-4852	excluded	_
35-12	4853-4857	from	_
35-13	4858-4862	both	_
35-14	4863-4867	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
35-15	4868-4871	and	_
35-16	4872-4875	MEG	_
35-17	4876-4884	analysis	_
35-18	4885-4886	(	_
35-19	4887-4896	technical	_
35-20	4897-4905	problems	_
35-21	4906-4909	and	_
35-22	4910-4911	a	_
35-23	4912-4919	failure	_
35-24	4920-4922	to	_
35-25	4923-4931	complete	_
35-26	4932-4935	the	_
35-27	4936-4940	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
35-28	4941-4946	study	_
35-29	4947-4948	)	_
35-30	4949-4950	.	_

Text=Four additional patients were excluded from the fMRI analysis: two because more than 20% of volumes yielded evidence of artifact as detected using the ArtRepair toolbox (; for further details, see fMRI analysis below), one because of a susceptibility artifact on the functional scans (of unknown origin), and one because of poor behavioral performance.
36-1	4951-4955	Four	_
36-2	4956-4966	additional	_
36-3	4967-4975	patients	_
36-4	4976-4980	were	_
36-5	4981-4989	excluded	_
36-6	4990-4994	from	_
36-7	4995-4998	the	_
36-8	4999-5003	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
36-9	5004-5012	analysis	_
36-10	5013-5014	:	_
36-11	5015-5018	two	_
36-12	5019-5026	because	_
36-13	5027-5031	more	_
36-14	5032-5036	than	_
36-15	5037-5039	20	_
36-16	5040-5041	%	_
36-17	5042-5044	of	_
36-18	5045-5052	volumes	_
36-19	5053-5060	yielded	_
36-20	5061-5069	evidence	_
36-21	5070-5072	of	_
36-22	5073-5081	artifact	_
36-23	5082-5084	as	_
36-24	5085-5093	detected	_
36-25	5094-5099	using	_
36-26	5100-5103	the	_
36-27	5104-5113	ArtRepair	_
36-28	5114-5121	toolbox	_
36-29	5122-5123	(	_
36-30	5124-5125	;	_
36-31	5126-5129	for	_
36-32	5130-5137	further	_
36-33	5138-5145	details	_
36-34	5146-5147	,	_
36-35	5148-5151	see	_
36-36	5152-5156	fMRI	_
36-37	5157-5165	analysis	_
36-38	5166-5171	below	_
36-39	5172-5173	)	_
36-40	5174-5175	,	_
36-41	5176-5179	one	_
36-42	5180-5187	because	_
36-43	5188-5190	of	_
36-44	5191-5192	a	_
36-45	5193-5207	susceptibility	_
36-46	5208-5216	artifact	_
36-47	5217-5219	on	_
36-48	5220-5223	the	_
36-49	5224-5234	functional	_
36-50	5235-5240	scans	_
36-51	5241-5242	(	_
36-52	5243-5245	of	_
36-53	5246-5253	unknown	_
36-54	5254-5260	origin	_
36-55	5261-5262	)	_
36-56	5263-5264	,	_
36-57	5265-5268	and	_
36-58	5269-5272	one	_
36-59	5273-5280	because	_
36-60	5281-5283	of	_
36-61	5284-5288	poor	_
36-62	5289-5299	behavioral	_
36-63	5300-5311	performance	_
36-64	5312-5313	.	_

Text=In addition, two patients failed to return for the MEG session.
37-1	5314-5316	In	_
37-2	5317-5325	addition	_
37-3	5326-5327	,	_
37-4	5328-5331	two	_
37-5	5332-5340	patients	_
37-6	5341-5347	failed	_
37-7	5348-5350	to	_
37-8	5351-5357	return	_
37-9	5358-5361	for	_
37-10	5362-5365	the	_
37-11	5366-5369	MEG	_
37-12	5370-5377	session	_
37-13	5378-5379	.	_

Text=In our analyses of the MEG and fMRI data, we included all participants who completed that session.
38-1	5380-5382	In	_
38-2	5383-5386	our	_
38-3	5387-5395	analyses	_
38-4	5396-5398	of	_
38-5	5399-5402	the	_
38-6	5403-5406	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
38-7	5407-5410	and	_
38-8	5411-5415	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
38-9	5416-5420	data	_
38-10	5421-5422	,	_
38-11	5423-5425	we	_
38-12	5426-5434	included	_
38-13	5435-5438	all	_
38-14	5439-5451	participants	_
38-15	5452-5455	who	_
38-16	5456-5465	completed	_
38-17	5466-5470	that	_
38-18	5471-5478	session	_
38-19	5479-5480	.	_

Text=Of these participants, 14 control participants and 18 people with schizophrenia participated in both fMRI and MEG sessions.
39-1	5481-5483	Of	_
39-2	5484-5489	these	_
39-3	5490-5502	participants	_
39-4	5503-5504	,	_
39-5	5505-5507	14	_
39-6	5508-5515	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
39-7	5516-5528	participants	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
39-8	5529-5532	and	_
39-9	5533-5535	18	_
39-10	5536-5542	people	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
39-11	5543-5547	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
39-12	5548-5561	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
39-13	5562-5574	participated	_
39-14	5575-5577	in	_
39-15	5578-5582	both	_
39-16	5583-5587	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
39-17	5588-5591	and	_
39-18	5592-5595	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
39-19	5596-5604	sessions	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
39-20	5605-5606	.	_

Text=We show the demographic and clinical data of this subset of participants in Table 1.
40-1	5607-5609	We	_
40-2	5610-5614	show	_
40-3	5615-5618	the	_
40-4	5619-5630	demographic	_
40-5	5631-5634	and	_
40-6	5635-5643	clinical	_
40-7	5644-5648	data	_
40-8	5649-5651	of	_
40-9	5652-5656	this	_
40-10	5657-5663	subset	_
40-11	5664-5666	of	_
40-12	5667-5679	participants	_
40-13	5680-5682	in	_
40-14	5683-5688	Table	_
40-15	5689-5690	1	_
40-16	5691-5692	.	_

Text=The two groups were matched closely on gender, race, and ethnicity, all ps> 0.1, and on age, years of education, and parental socioeconomic status, all ps> 0.3.
41-1	5693-5696	The	_
41-2	5697-5700	two	_
41-3	5701-5707	groups	_
41-4	5708-5712	were	_
41-5	5713-5720	matched	_
41-6	5721-5728	closely	_
41-7	5729-5731	on	_
41-8	5732-5738	gender	_
41-9	5739-5740	,	_
41-10	5741-5745	race	_
41-11	5746-5747	,	_
41-12	5748-5751	and	_
41-13	5752-5761	ethnicity	_
41-14	5762-5763	,	_
41-15	5764-5767	all	_
41-16	5768-5770	ps	_
41-17	5771-5772	>	_
41-18	5773-5776	0.1	_
41-19	5777-5778	,	_
41-20	5779-5782	and	_
41-21	5783-5785	on	_
41-22	5786-5789	age	_
41-23	5790-5791	,	_
41-24	5792-5797	years	_
41-25	5798-5800	of	_
41-26	5801-5810	education	_
41-27	5811-5812	,	_
41-28	5813-5816	and	_
41-29	5817-5825	parental	_
41-30	5826-5839	socioeconomic	_
41-31	5840-5846	status	_
41-32	5847-5848	,	_
41-33	5849-5852	all	_
41-34	5853-5855	ps	_
41-35	5856-5857	>	_
41-36	5858-5861	0.3	_
41-37	5862-5863	.	_

Text=Premorbid verbal IQ, assessed with the North American Adult Reading Test, was slightly lower in the patient than the control group (t (30) = 2.103, p = 0.044).
42-1	5864-5873	Premorbid	_
42-2	5874-5880	verbal	_
42-3	5881-5883	IQ	_
42-4	5884-5885	,	_
42-5	5886-5894	assessed	_
42-6	5895-5899	with	_
42-7	5900-5903	the	_
42-8	5904-5909	North	_
42-9	5910-5918	American	_
42-10	5919-5924	Adult	_
42-11	5925-5932	Reading	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
42-12	5933-5937	Test	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
42-13	5938-5939	,	_
42-14	5940-5943	was	_
42-15	5944-5952	slightly	_
42-16	5953-5958	lower	_
42-17	5959-5961	in	_
42-18	5962-5965	the	_
42-19	5966-5973	patient	_
42-20	5974-5978	than	_
42-21	5979-5982	the	_
42-22	5983-5990	control	_
42-23	5991-5996	group	_
42-24	5997-5998	(	_
42-25	5999-6000	t	_
42-26	6001-6002	(	_
42-27	6003-6005	30	_
42-28	6006-6007	)	_
42-29	6008-6009	=	_
42-30	6010-6015	2.103	_
42-31	6016-6017	,	_
42-32	6018-6019	p	_
42-33	6020-6021	=	_
42-34	6022-6027	0.044	_
42-35	6028-6029	)	_
42-36	6030-6031	.	_

Text=Overall procedure For the subset of participants who completed both MEG and MRI sessions, these sessions were carried out on different days, with a minimum of two days in between sessions.
43-1	6032-6039	Overall	_
43-2	6040-6049	procedure	_
43-3	6050-6053	For	_
43-4	6054-6057	the	_
43-5	6058-6064	subset	_
43-6	6065-6067	of	_
43-7	6068-6080	participants	_
43-8	6081-6084	who	_
43-9	6085-6094	completed	_
43-10	6095-6099	both	_
43-11	6100-6103	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
43-12	6104-6107	and	_
43-13	6108-6111	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
43-14	6112-6120	sessions	_
43-15	6121-6122	,	_
43-16	6123-6128	these	_
43-17	6129-6137	sessions	_
43-18	6138-6142	were	_
43-19	6143-6150	carried	_
43-20	6151-6154	out	_
43-21	6155-6157	on	_
43-22	6158-6167	different	_
43-23	6168-6172	days	_
43-24	6173-6174	,	_
43-25	6175-6179	with	_
43-26	6180-6181	a	_
43-27	6182-6189	minimum	_
43-28	6190-6192	of	_
43-29	6193-6196	two	_
43-30	6197-6201	days	_
43-31	6202-6204	in	_
43-32	6205-6212	between	_
43-33	6213-6221	sessions	_
43-34	6222-6223	.	_

Text=The order of these sessions was counterbalanced across participants.
44-1	6224-6227	The	_
44-2	6228-6233	order	_
44-3	6234-6236	of	_
44-4	6237-6242	these	_
44-5	6243-6251	sessions	_
44-6	6252-6255	was	_
44-7	6256-6271	counterbalanced	_
44-8	6272-6278	across	_
44-9	6279-6291	participants	_
44-10	6292-6293	.	_

Text=In addition, participants were assigned different lists in each session so that no participant saw the same list (or target word) twice.
45-1	6294-6296	In	_
45-2	6297-6305	addition	_
45-3	6306-6307	,	_
45-4	6308-6320	participants	_
45-5	6321-6325	were	_
45-6	6326-6334	assigned	_
45-7	6335-6344	different	_
45-8	6345-6350	lists	_
45-9	6351-6353	in	_
45-10	6354-6358	each	_
45-11	6359-6366	session	_
45-12	6367-6369	so	_
45-13	6370-6374	that	_
45-14	6375-6377	no	_
45-15	6378-6389	participant	_
45-16	6390-6393	saw	_
45-17	6394-6397	the	_
45-18	6398-6402	same	_
45-19	6403-6407	list	_
45-20	6408-6409	(	_
45-21	6410-6412	or	_
45-22	6413-6419	target	_
45-23	6420-6424	word	_
45-24	6425-6426	)	_
45-25	6427-6432	twice	_
45-26	6433-6434	.	_

Text=Stimuli presentation and task The structure of trials is shown in Fig.
46-1	6435-6442	Stimuli	_
46-2	6443-6455	presentation	_
46-3	6456-6459	and	_
46-4	6460-6464	task	_
46-5	6465-6468	The	_
46-6	6469-6478	structure	_
46-7	6479-6481	of	_
46-8	6482-6488	trials	_
46-9	6489-6491	is	_
46-10	6492-6497	shown	_
46-11	6498-6500	in	_
46-12	6501-6504	Fig	_
46-13	6505-6506	.	_

Text=2.
47-1	6507-6508	2	_
47-2	6509-6510	.	_

Text=For fMRI, additional fixations (2–8 s) were added after 25% of trials to optimize the de­convolution of the event-related hemodynamic response function (; see https: //surfer.nmr.mgh.harvard.edu/optseq).
48-1	6511-6514	For	_
48-2	6515-6519	fMRI	_
48-3	6520-6521	,	_
48-4	6522-6532	additional	_
48-5	6533-6542	fixations	_
48-6	6543-6544	(	_
48-7	6545-6548	2–8	_
48-8	6549-6550	s	_
48-9	6551-6552	)	_
48-10	6553-6557	were	_
48-11	6558-6563	added	_
48-12	6564-6569	after	_
48-13	6570-6572	25	_
48-14	6573-6574	%	_
48-15	6575-6577	of	_
48-16	6578-6584	trials	_
48-17	6585-6587	to	_
48-18	6588-6596	optimize	_
48-19	6597-6600	the	_
48-20	6601-6615	de­convolution	_
48-21	6616-6618	of	_
48-22	6619-6622	the	_
48-23	6623-6636	event-related	_
48-24	6637-6648	hemodynamic	_
48-25	6649-6657	response	_
48-26	6658-6666	function	_
48-27	6667-6668	(	_
48-28	6669-6670	;	_
48-29	6671-6674	see	_
48-30	6675-6680	https	_
48-31	6681-6682	:	_
48-32	6683-6718	//surfer.nmr.mgh.harvard.edu/optseq	_
48-33	6719-6720	)	_
48-34	6721-6722	.	_

Text=For MEG, at least 700 ms was inserted between trials, allowing participants time to blink.
49-1	6723-6726	For	_
49-2	6727-6730	MEG	_
49-3	6731-6732	,	_
49-4	6733-6735	at	_
49-5	6736-6741	least	_
49-6	6742-6745	700	_
49-7	6746-6748	ms	_
49-8	6749-6752	was	_
49-9	6753-6761	inserted	_
49-10	6762-6769	between	_
49-11	6770-6776	trials	_
49-12	6777-6778	,	_
49-13	6779-6787	allowing	_
49-14	6788-6800	participants	_
49-15	6801-6805	time	_
49-16	6806-6808	to	_
49-17	6809-6814	blink	_
49-18	6815-6816	.	_

Text=In both sessions, participants carried out a semantic monitoring task: to press a response button as quickly as possible whenever they saw an insect word, regardless of whether it appeared in the prime or target position.
50-1	6817-6819	In	_
50-2	6820-6824	both	_
50-3	6825-6833	sessions	_
50-4	6834-6835	,	_
50-5	6836-6848	participants	_
50-6	6849-6856	carried	_
50-7	6857-6860	out	_
50-8	6861-6862	a	_
50-9	6863-6871	semantic	_
50-10	6872-6882	monitoring	_
50-11	6883-6887	task	_
50-12	6888-6889	:	_
50-13	6890-6892	to	_
50-14	6893-6898	press	_
50-15	6899-6900	a	_
50-16	6901-6909	response	_
50-17	6910-6916	button	_
50-18	6917-6919	as	_
50-19	6920-6927	quickly	_
50-20	6928-6930	as	_
50-21	6931-6939	possible	_
50-22	6940-6948	whenever	_
50-23	6949-6953	they	_
50-24	6954-6957	saw	_
50-25	6958-6960	an	_
50-26	6961-6967	insect	_
50-27	6968-6972	word	_
50-28	6973-6974	,	_
50-29	6975-6985	regardless	_
50-30	6986-6988	of	_
50-31	6989-6996	whether	_
50-32	6997-6999	it	_
50-33	7000-7008	appeared	_
50-34	7009-7011	in	_
50-35	7012-7015	the	_
50-36	7016-7021	prime	_
50-37	7022-7024	or	_
50-38	7025-7031	target	_
50-39	7032-7040	position	_
50-40	7041-7042	.	_

Text=Responses were considered accurate if they were registered within 5 s of prime onset.
51-1	7043-7052	Responses	_
51-2	7053-7057	were	_
51-3	7058-7068	considered	_
51-4	7069-7077	accurate	_
51-5	7078-7080	if	_
51-6	7081-7085	they	_
51-7	7086-7090	were	_
51-8	7091-7101	registered	_
51-9	7102-7108	within	_
51-10	7109-7110	5	_
51-11	7111-7112	s	_
51-12	7113-7115	of	_
51-13	7116-7121	prime	_
51-14	7122-7127	onset	_
51-15	7128-7129	.	_

Text=Trials were presented in two runs, separated by a short break.
52-1	7130-7136	Trials	_
52-2	7137-7141	were	http://maven.renci.org/NeuroBridge/neurobridge#Immunoelectrophoresis
52-3	7142-7151	presented	http://maven.renci.org/NeuroBridge/neurobridge#Immunoelectrophoresis
52-4	7152-7154	in	http://maven.renci.org/NeuroBridge/neurobridge#Immunoelectrophoresis
52-5	7155-7158	two	http://maven.renci.org/NeuroBridge/neurobridge#Immunoelectrophoresis
52-6	7159-7163	runs	http://maven.renci.org/NeuroBridge/neurobridge#Immunoelectrophoresis
52-7	7164-7165	,	_
52-8	7166-7175	separated	_
52-9	7176-7178	by	_
52-10	7179-7180	a	_
52-11	7181-7186	short	_
52-12	7187-7192	break	_
52-13	7193-7194	.	_

Text=A brief practice session preceded both the MEG and fMRI sessions.
53-1	7195-7196	A	_
53-2	7197-7202	brief	_
53-3	7203-7211	practice	_
53-4	7212-7219	session	_
53-5	7220-7228	preceded	_
53-6	7229-7233	both	_
53-7	7234-7237	the	_
53-8	7238-7241	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
53-9	7242-7245	and	_
53-10	7246-7250	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
53-11	7251-7259	sessions	_
53-12	7260-7261	.	_

Text=MEG acquisition MEG data was acquired inside a magnetically shielded room (IMEDCO AG, Switzerland) using a Neuromag VectorView system (Elekta-Neuromag Oy, Finland; 102 sets of triplet sensors — two orthogonal planar gradiometers and one magnetometer), with an online bandpass filter of 0.03–200 Hz and continuously sampled at 600 Hz.
54-1	7262-7265	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
54-2	7266-7277	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
54-3	7278-7281	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
54-4	7282-7286	data	_
54-5	7287-7290	was	_
54-6	7291-7299	acquired	_
54-7	7300-7306	inside	_
54-8	7307-7308	a	_
54-9	7309-7321	magnetically	_
54-10	7322-7330	shielded	_
54-11	7331-7335	room	_
54-12	7336-7337	(	_
54-13	7338-7344	IMEDCO	_
54-14	7345-7347	AG	_
54-15	7348-7349	,	_
54-16	7350-7361	Switzerland	_
54-17	7362-7363	)	_
54-18	7364-7369	using	_
54-19	7370-7371	a	_
54-20	7372-7380	Neuromag	_
54-21	7381-7391	VectorView	_
54-22	7392-7398	system	_
54-23	7399-7400	(	_
54-24	7401-7416	Elekta-Neuromag	_
54-25	7417-7419	Oy	_
54-26	7420-7421	,	_
54-27	7422-7429	Finland	_
54-28	7430-7431	;	_
54-29	7432-7435	102	_
54-30	7436-7440	sets	_
54-31	7441-7443	of	_
54-32	7444-7451	triplet	_
54-33	7452-7459	sensors	_
54-34	7460-7461	—	_
54-35	7462-7465	two	_
54-36	7466-7476	orthogonal	_
54-37	7477-7483	planar	_
54-38	7484-7496	gradiometers	_
54-39	7497-7500	and	_
54-40	7501-7504	one	_
54-41	7505-7517	magnetometer	_
54-42	7518-7519	)	_
54-43	7520-7521	,	_
54-44	7522-7526	with	_
54-45	7527-7529	an	_
54-46	7530-7536	online	_
54-47	7537-7545	bandpass	_
54-48	7546-7552	filter	_
54-49	7553-7555	of	_
54-50	7556-7564	0.03–200	_
54-51	7565-7567	Hz	_
54-52	7568-7571	and	_
54-53	7572-7584	continuously	_
54-54	7585-7592	sampled	_
54-55	7593-7595	at	_
54-56	7596-7599	600	_
54-57	7600-7602	Hz	_
54-58	7603-7604	.	_

Text=We also collected EEG, EOG, and ECG data using a 70-channel MEG-compatible electrode system.
55-1	7605-7607	We	_
55-2	7608-7612	also	_
55-3	7613-7622	collected	_
55-4	7623-7626	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
55-5	7627-7628	,	_
55-6	7629-7632	EOG	http://maven.renci.org/NeuroBridge/neurobridge#ElectrooculogramInstrument
55-7	7633-7634	,	_
55-8	7635-7638	and	_
55-9	7639-7642	ECG	http://maven.renci.org/NeuroBridge/neurobridge#MeasurementData
55-10	7643-7647	data	_
55-11	7648-7653	using	_
55-12	7654-7655	a	_
55-13	7656-7666	70-channel	_
55-14	7667-7681	MEG-compatible	_
55-15	7682-7691	electrode	_
55-16	7692-7698	system	_
55-17	7699-7700	.	_

Text=The EEG data are not reported here.
56-1	7701-7704	The	_
56-2	7705-7708	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
56-3	7709-7713	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
56-4	7714-7717	are	_
56-5	7718-7721	not	_
56-6	7722-7730	reported	_
56-7	7731-7735	here	_
56-8	7736-7737	.	_

Text=To record the position and orientation of the head with respect to the MEG sensor array, at the beginning of each run, the locations of three fiduciary points (nasion and two auricular), four head position indicator coils, the EEG electrodes, and 100+ additional points were digitized using a 3Space Fastrak Polhemus digitizer integrated with the Vectorview system.
57-1	7738-7740	To	_
57-2	7741-7747	record	_
57-3	7748-7751	the	_
57-4	7752-7760	position	_
57-5	7761-7764	and	_
57-6	7765-7776	orientation	_
57-7	7777-7779	of	_
57-8	7780-7783	the	_
57-9	7784-7788	head	_
57-10	7789-7793	with	_
57-11	7794-7801	respect	_
57-12	7802-7804	to	_
57-13	7805-7808	the	_
57-14	7809-7812	MEG	_
57-15	7813-7819	sensor	_
57-16	7820-7825	array	_
57-17	7826-7827	,	_
57-18	7828-7830	at	_
57-19	7831-7834	the	_
57-20	7835-7844	beginning	_
57-21	7845-7847	of	_
57-22	7848-7852	each	_
57-23	7853-7856	run	_
57-24	7857-7858	,	_
57-25	7859-7862	the	_
57-26	7863-7872	locations	_
57-27	7873-7875	of	_
57-28	7876-7881	three	_
57-29	7882-7891	fiduciary	_
57-30	7892-7898	points	_
57-31	7899-7900	(	_
57-32	7901-7907	nasion	_
57-33	7908-7911	and	_
57-34	7912-7915	two	_
57-35	7916-7925	auricular	_
57-36	7926-7927	)	_
57-37	7928-7929	,	_
57-38	7930-7934	four	_
57-39	7935-7939	head	_
57-40	7940-7948	position	_
57-41	7949-7958	indicator	_
57-42	7959-7964	coils	_
57-43	7965-7966	,	_
57-44	7967-7970	the	_
57-45	7971-7974	EEG	_
57-46	7975-7985	electrodes	_
57-47	7986-7987	,	_
57-48	7988-7991	and	_
57-49	7992-7996	100+	_
57-50	7997-8007	additional	_
57-51	8008-8014	points	_
57-52	8015-8019	were	_
57-53	8020-8029	digitized	_
57-54	8030-8035	using	_
57-55	8036-8037	a	_
57-56	8038-8044	3Space	_
57-57	8045-8052	Fastrak	_
57-58	8053-8061	Polhemus	_
57-59	8062-8071	digitizer	_
57-60	8072-8082	integrated	_
57-61	8083-8087	with	_
57-62	8088-8091	the	_
57-63	8092-8102	Vectorview	_
57-64	8103-8109	system	_
57-65	8110-8111	.	_

Text=FMRI acquisition fMRI images were acquired using a 3T Siemens Trio scanner and a 32-channel head coil using a gradient-echo sequence (TR, 2 s; TE, 25 ms; flip angle 90°; interleaved acquisition) over two runs (each 148 functional volumes; 36 axial slices anterior commissure-posterior commissure aligned, 3 mm slice thickness, 0.3 mm skip, 200 mm field of view, in-plane resolution of 3.125 mm).
58-1	8112-8116	FMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
58-2	8117-8128	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
58-3	8129-8133	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
58-4	8134-8140	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
58-5	8141-8145	were	_
58-6	8146-8154	acquired	_
58-7	8155-8160	using	_
58-8	8161-8162	a	_
58-9	8163-8165	3T	_
58-10	8166-8173	Siemens	_
58-11	8174-8178	Trio	_
58-12	8179-8186	scanner	_
58-13	8187-8190	and	_
58-14	8191-8192	a	_
58-15	8193-8203	32-channel	_
58-16	8204-8208	head	_
58-17	8209-8213	coil	_
58-18	8214-8219	using	_
58-19	8220-8221	a	_
58-20	8222-8235	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
58-21	8236-8244	sequence	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
58-22	8245-8246	(	_
58-23	8247-8249	TR	_
58-24	8250-8251	,	_
58-25	8252-8253	2	_
58-26	8254-8255	s	_
58-27	8256-8257	;	_
58-28	8258-8260	TE	_
58-29	8261-8262	,	_
58-30	8263-8265	25	_
58-31	8266-8268	ms	_
58-32	8269-8270	;	_
58-33	8271-8275	flip	_
58-34	8276-8281	angle	_
58-35	8282-8285	90°	_
58-36	8286-8287	;	_
58-37	8288-8299	interleaved	_
58-38	8300-8311	acquisition	_
58-39	8312-8313	)	_
58-40	8314-8318	over	_
58-41	8319-8322	two	_
58-42	8323-8327	runs	_
58-43	8328-8329	(	_
58-44	8330-8334	each	_
58-45	8335-8338	148	_
58-46	8339-8349	functional	_
58-47	8350-8357	volumes	_
58-48	8358-8359	;	_
58-49	8360-8362	36	_
58-50	8363-8368	axial	_
58-51	8369-8375	slices	_
58-52	8376-8384	anterior	_
58-53	8385-8405	commissure-posterior	_
58-54	8406-8416	commissure	_
58-55	8417-8424	aligned	_
58-56	8425-8426	,	_
58-57	8427-8428	3	_
58-58	8429-8431	mm	_
58-59	8432-8437	slice	_
58-60	8438-8447	thickness	_
58-61	8448-8449	,	_
58-62	8450-8453	0.3	_
58-63	8454-8456	mm	_
58-64	8457-8461	skip	_
58-65	8462-8463	,	_
58-66	8464-8467	200	_
58-67	8468-8470	mm	_
58-68	8471-8476	field	_
58-69	8477-8479	of	_
58-70	8480-8484	view	_
58-71	8485-8486	,	_
58-72	8487-8495	in-plane	_
58-73	8496-8506	resolution	_
58-74	8507-8509	of	_
58-75	8510-8515	3.125	_
58-76	8516-8518	mm	_
58-77	8519-8520	)	_
58-78	8521-8522	.	_

Text=We also acquired structural images at the beginning and the end of the session.
59-1	8523-8525	We	_
59-2	8526-8530	also	_
59-3	8531-8539	acquired	_
59-4	8540-8550	structural	_
59-5	8551-8557	images	_
59-6	8558-8560	at	_
59-7	8561-8564	the	_
59-8	8565-8574	beginning	_
59-9	8575-8578	and	_
59-10	8579-8582	the	_
59-11	8583-8586	end	_
59-12	8587-8589	of	_
59-13	8590-8593	the	_
59-14	8594-8601	session	_
59-15	8602-8603	.	_

Text=MEG preprocessing Signal-space projection (SSP) was applied to MEG magnetometer data to suppress environmental noise and biological artifacts.
60-1	8604-8607	MEG	_
60-2	8608-8621	preprocessing	_
60-3	8622-8634	Signal-space	_
60-4	8635-8645	projection	_
60-5	8646-8647	(	_
60-6	8648-8651	SSP	_
60-7	8652-8653	)	_
60-8	8654-8657	was	_
60-9	8658-8665	applied	_
60-10	8666-8668	to	_
60-11	8669-8672	MEG	_
60-12	8673-8685	magnetometer	_
60-13	8686-8690	data	_
60-14	8691-8693	to	_
60-15	8694-8702	suppress	_
60-16	8703-8716	environmental	_
60-17	8717-8722	noise	_
60-18	8723-8726	and	_
60-19	8727-8737	biological	_
60-20	8738-8747	artifacts	_
60-21	8748-8749	.	_

Text=Additional SSPs were computed to estimate cardiac artifacts (detected using the bipolar ECG electrodes) and ocular artifacts (detected using the bipolar VEOG electrodes) and applied to the MEG gradiometer and magnetometer data.
61-1	8750-8760	Additional	_
61-2	8761-8765	SSPs	_
61-3	8766-8770	were	_
61-4	8771-8779	computed	_
61-5	8780-8782	to	_
61-6	8783-8791	estimate	_
61-7	8792-8799	cardiac	_
61-8	8800-8809	artifacts	_
61-9	8810-8811	(	_
61-10	8812-8820	detected	_
61-11	8821-8826	using	_
61-12	8827-8830	the	_
61-13	8831-8838	bipolar	_
61-14	8839-8842	ECG	_
61-15	8843-8853	electrodes	_
61-16	8854-8855	)	_
61-17	8856-8859	and	_
61-18	8860-8866	ocular	_
61-19	8867-8876	artifacts	_
61-20	8877-8878	(	_
61-21	8879-8887	detected	_
61-22	8888-8893	using	_
61-23	8894-8897	the	_
61-24	8898-8905	bipolar	_
61-25	8906-8910	VEOG	_
61-26	8911-8921	electrodes	_
61-27	8922-8923	)	_
61-28	8924-8927	and	_
61-29	8928-8935	applied	_
61-30	8936-8938	to	_
61-31	8939-8942	the	_
61-32	8943-8946	MEG	_
61-33	8947-8958	gradiometer	_
61-34	8959-8962	and	_
61-35	8963-8975	magnetometer	_
61-36	8976-8980	data	_
61-37	8981-8982	.	_

Text=Averaged event-related MEG signals were computed off-line from trials free of muscular artifacts after the application of a 20 Hz off-line low-pass filter.
62-1	8983-8991	Averaged	_
62-2	8992-9005	event-related	_
62-3	9006-9009	MEG	_
62-4	9010-9017	signals	_
62-5	9018-9022	were	_
62-6	9023-9031	computed	_
62-7	9032-9040	off-line	_
62-8	9041-9045	from	_
62-9	9046-9052	trials	_
62-10	9053-9057	free	_
62-11	9058-9060	of	_
62-12	9061-9069	muscular	_
62-13	9070-9079	artifacts	_
62-14	9080-9085	after	_
62-15	9086-9089	the	_
62-16	9090-9101	application	_
62-17	9102-9104	of	_
62-18	9105-9106	a	_
62-19	9107-9109	20	_
62-20	9110-9112	Hz	_
62-21	9113-9121	off-line	_
62-22	9122-9130	low-pass	_
62-23	9131-9137	filter	_
62-24	9138-9139	.	_

Text=We then combined activity across the two planar gradiometers at each site, and calculated activity time-locked to target words in each condition using a baseline of −100 ms. We generated difference waveforms corresponding to the indirect and direct priming effects, and averaged these difference waveforms across 13 temporal sites where previous MEG studies have reported maximal modulation within the N400 time window (e.g.
63-1	9140-9142	We	_
63-2	9143-9147	then	_
63-3	9148-9156	combined	_
63-4	9157-9165	activity	_
63-5	9166-9172	across	_
63-6	9173-9176	the	_
63-7	9177-9180	two	_
63-8	9181-9187	planar	_
63-9	9188-9200	gradiometers	_
63-10	9201-9203	at	_
63-11	9204-9208	each	_
63-12	9209-9213	site	_
63-13	9214-9215	,	_
63-14	9216-9219	and	_
63-15	9220-9230	calculated	_
63-16	9231-9239	activity	_
63-17	9240-9251	time-locked	_
63-18	9252-9254	to	_
63-19	9255-9261	target	_
63-20	9262-9267	words	_
63-21	9268-9270	in	_
63-22	9271-9275	each	_
63-23	9276-9285	condition	_
63-24	9286-9291	using	_
63-25	9292-9293	a	_
63-26	9294-9302	baseline	_
63-27	9303-9305	of	_
63-28	9306-9310	−100	_
63-29	9311-9314	ms.	_
63-30	9315-9317	We	_
63-31	9318-9327	generated	_
63-32	9328-9338	difference	_
63-33	9339-9348	waveforms	_
63-34	9349-9362	corresponding	_
63-35	9363-9365	to	_
63-36	9366-9369	the	_
63-37	9370-9378	indirect	_
63-38	9379-9382	and	_
63-39	9383-9389	direct	_
63-40	9390-9397	priming	_
63-41	9398-9405	effects	_
63-42	9406-9407	,	_
63-43	9408-9411	and	_
63-44	9412-9420	averaged	_
63-45	9421-9426	these	_
63-46	9427-9437	difference	_
63-47	9438-9447	waveforms	_
63-48	9448-9454	across	_
63-49	9455-9457	13	_
63-50	9458-9466	temporal	_
63-51	9467-9472	sites	_
63-52	9473-9478	where	_
63-53	9479-9487	previous	_
63-54	9488-9491	MEG	_
63-55	9492-9499	studies	_
63-56	9500-9504	have	_
63-57	9505-9513	reported	_
63-58	9514-9521	maximal	_
63-59	9522-9532	modulation	_
63-60	9533-9539	within	_
63-61	9540-9543	the	_
63-62	9544-9548	N400	_
63-63	9549-9553	time	_
63-64	9554-9560	window	_
63-65	9561-9562	(	_
63-66	9563-9566	e.g	_
63-67	9567-9568	.	_

Text=;).
64-1	9569-9570	;	_
64-2	9571-9572	)	_
64-3	9573-9574	.	_

Text=MEG statistical analysis To determine whether the indirect or the direct priming effects differed between the schizophrenia and control groups, we used a mass univariate approach: We carried out independent-samples t-tests (comparing the two groups) at each sampling point (60 data points) on the difference waveforms (unrelated minus directly related; unrelated minus indirectly related) within the 300–500 ms time window of interest, averaged over the temporal sites.
65-1	9575-9578	MEG	_
65-2	9579-9590	statistical	_
65-3	9591-9599	analysis	_
65-4	9600-9602	To	_
65-5	9603-9612	determine	_
65-6	9613-9620	whether	_
65-7	9621-9624	the	_
65-8	9625-9633	indirect	_
65-9	9634-9636	or	_
65-10	9637-9640	the	_
65-11	9641-9647	direct	_
65-12	9648-9655	priming	_
65-13	9656-9663	effects	_
65-14	9664-9672	differed	_
65-15	9673-9680	between	_
65-16	9681-9684	the	_
65-17	9685-9698	schizophrenia	_
65-18	9699-9702	and	_
65-19	9703-9710	control	_
65-20	9711-9717	groups	_
65-21	9718-9719	,	_
65-22	9720-9722	we	_
65-23	9723-9727	used	_
65-24	9728-9729	a	_
65-25	9730-9734	mass	_
65-26	9735-9745	univariate	_
65-27	9746-9754	approach	_
65-28	9755-9756	:	_
65-29	9757-9759	We	_
65-30	9760-9767	carried	_
65-31	9768-9771	out	_
65-32	9772-9791	independent-samples	_
65-33	9792-9799	t-tests	_
65-34	9800-9801	(	_
65-35	9802-9811	comparing	_
65-36	9812-9815	the	_
65-37	9816-9819	two	_
65-38	9820-9826	groups	_
65-39	9827-9828	)	_
65-40	9829-9831	at	_
65-41	9832-9836	each	_
65-42	9837-9845	sampling	_
65-43	9846-9851	point	_
65-44	9852-9853	(	_
65-45	9854-9856	60	_
65-46	9857-9861	data	_
65-47	9862-9868	points	_
65-48	9869-9870	)	_
65-49	9871-9873	on	_
65-50	9874-9877	the	_
65-51	9878-9888	difference	_
65-52	9889-9898	waveforms	_
65-53	9899-9900	(	_
65-54	9901-9910	unrelated	_
65-55	9911-9916	minus	_
65-56	9917-9925	directly	_
65-57	9926-9933	related	_
65-58	9934-9935	;	_
65-59	9936-9945	unrelated	_
65-60	9946-9951	minus	_
65-61	9952-9962	indirectly	_
65-62	9963-9970	related	_
65-63	9971-9972	)	_
65-64	9973-9979	within	_
65-65	9980-9983	the	_
65-66	9984-9991	300–500	_
65-67	9992-9994	ms	_
65-68	9995-9999	time	_
65-69	10000-10006	window	_
65-70	10007-10009	of	_
65-71	10010-10018	interest	_
65-72	10019-10020	,	_
65-73	10021-10029	averaged	_
65-74	10030-10034	over	_
65-75	10035-10038	the	_
65-76	10039-10047	temporal	_
65-77	10048-10053	sites	_
65-78	10054-10055	.	_

Text=We used cluster-based permutation tests to account for multiple comparisons using an open-source Matlab toolbox within the Fieldtrip software package.
66-1	10056-10058	We	_
66-2	10059-10063	used	_
66-3	10064-10077	cluster-based	_
66-4	10078-10089	permutation	_
66-5	10090-10095	tests	_
66-6	10096-10098	to	_
66-7	10099-10106	account	_
66-8	10107-10110	for	_
66-9	10111-10119	multiple	_
66-10	10120-10131	comparisons	_
66-11	10132-10137	using	_
66-12	10138-10140	an	_
66-13	10141-10152	open-source	_
66-14	10153-10159	Matlab	_
66-15	10160-10167	toolbox	_
66-16	10168-10174	within	_
66-17	10175-10178	the	_
66-18	10179-10188	Fieldtrip	_
66-19	10189-10197	software	_
66-20	10198-10205	package	_
66-21	10206-10207	.	_

Text=Consecutive data points that exceeded a pre-set uncorrected significance threshold of 5% were considered a cluster, and individual t-statistics within each cluster were summed to yield cluster-level test statistics.
67-1	10208-10219	Consecutive	_
67-2	10220-10224	data	_
67-3	10225-10231	points	_
67-4	10232-10236	that	_
67-5	10237-10245	exceeded	_
67-6	10246-10247	a	_
67-7	10248-10255	pre-set	_
67-8	10256-10267	uncorrected	_
67-9	10268-10280	significance	_
67-10	10281-10290	threshold	_
67-11	10291-10293	of	_
67-12	10294-10295	5	_
67-13	10296-10297	%	_
67-14	10298-10302	were	_
67-15	10303-10313	considered	_
67-16	10314-10315	a	_
67-17	10316-10323	cluster	_
67-18	10324-10325	,	_
67-19	10326-10329	and	_
67-20	10330-10340	individual	_
67-21	10341-10353	t-statistics	_
67-22	10354-10360	within	_
67-23	10361-10365	each	_
67-24	10366-10373	cluster	_
67-25	10374-10378	were	_
67-26	10379-10385	summed	_
67-27	10386-10388	to	_
67-28	10389-10394	yield	_
67-29	10395-10408	cluster-level	_
67-30	10409-10413	test	_
67-31	10414-10424	statistics	_
67-32	10425-10426	.	_

Text=Next, a null distribution was created by randomly assigning difference values at each sampling point to either the schizophrenia or the control group 1000 times, calculating cluster-level statistics for each randomization and entering the largest cluster-level summed t statistic into the null distribution.
68-1	10427-10431	Next	_
68-2	10432-10433	,	_
68-3	10434-10435	a	_
68-4	10436-10440	null	_
68-5	10441-10453	distribution	_
68-6	10454-10457	was	_
68-7	10458-10465	created	_
68-8	10466-10468	by	_
68-9	10469-10477	randomly	_
68-10	10478-10487	assigning	_
68-11	10488-10498	difference	_
68-12	10499-10505	values	_
68-13	10506-10508	at	_
68-14	10509-10513	each	_
68-15	10514-10522	sampling	_
68-16	10523-10528	point	_
68-17	10529-10531	to	_
68-18	10532-10538	either	_
68-19	10539-10542	the	_
68-20	10543-10556	schizophrenia	_
68-21	10557-10559	or	_
68-22	10560-10563	the	_
68-23	10564-10571	control	_
68-24	10572-10577	group	_
68-25	10578-10582	1000	_
68-26	10583-10588	times	_
68-27	10589-10590	,	_
68-28	10591-10602	calculating	_
68-29	10603-10616	cluster-level	_
68-30	10617-10627	statistics	_
68-31	10628-10631	for	_
68-32	10632-10636	each	_
68-33	10637-10650	randomization	_
68-34	10651-10654	and	_
68-35	10655-10663	entering	_
68-36	10664-10667	the	_
68-37	10668-10675	largest	_
68-38	10676-10689	cluster-level	_
68-39	10690-10696	summed	_
68-40	10697-10698	t	_
68-41	10699-10708	statistic	_
68-42	10709-10713	into	_
68-43	10714-10717	the	_
68-44	10718-10722	null	_
68-45	10723-10735	distribution	_
68-46	10736-10737	.	_

Text=The actually observed cluster-level test statistics were compared with the null distribution, and any clusters falling within the highest or the lowest 2.5th percentile were considered significant.
69-1	10738-10741	The	_
69-2	10742-10750	actually	_
69-3	10751-10759	observed	_
69-4	10760-10773	cluster-level	_
69-5	10774-10778	test	_
69-6	10779-10789	statistics	_
69-7	10790-10794	were	_
69-8	10795-10803	compared	_
69-9	10804-10808	with	_
69-10	10809-10812	the	_
69-11	10813-10817	null	_
69-12	10818-10830	distribution	_
69-13	10831-10832	,	_
69-14	10833-10836	and	_
69-15	10837-10840	any	_
69-16	10841-10849	clusters	_
69-17	10850-10857	falling	_
69-18	10858-10864	within	_
69-19	10865-10868	the	_
69-20	10869-10876	highest	_
69-21	10877-10879	or	_
69-22	10880-10883	the	_
69-23	10884-10890	lowest	_
69-24	10891-10896	2.5th	_
69-25	10897-10907	percentile	_
69-26	10908-10912	were	_
69-27	10913-10923	considered	_
69-28	10924-10935	significant	_
69-29	10936-10937	.	_

Text=To follow up any significant between-group differences, we examined priming effects within each group separately by carrying out dependent sample t-tests between conditions at each sampling point between 300 and 500 ms, and once again using a cluster-based permutation approach to account for multiple comparisons.
70-1	10938-10940	To	_
70-2	10941-10947	follow	_
70-3	10948-10950	up	_
70-4	10951-10954	any	_
70-5	10955-10966	significant	_
70-6	10967-10980	between-group	_
70-7	10981-10992	differences	_
70-8	10993-10994	,	_
70-9	10995-10997	we	_
70-10	10998-11006	examined	_
70-11	11007-11014	priming	_
70-12	11015-11022	effects	_
70-13	11023-11029	within	_
70-14	11030-11034	each	_
70-15	11035-11040	group	_
70-16	11041-11051	separately	_
70-17	11052-11054	by	_
70-18	11055-11063	carrying	_
70-19	11064-11067	out	_
70-20	11068-11077	dependent	_
70-21	11078-11084	sample	_
70-22	11085-11092	t-tests	_
70-23	11093-11100	between	_
70-24	11101-11111	conditions	_
70-25	11112-11114	at	_
70-26	11115-11119	each	_
70-27	11120-11128	sampling	_
70-28	11129-11134	point	_
70-29	11135-11142	between	_
70-30	11143-11146	300	_
70-31	11147-11150	and	_
70-32	11151-11154	500	_
70-33	11155-11157	ms	_
70-34	11158-11159	,	_
70-35	11160-11163	and	_
70-36	11164-11168	once	_
70-37	11169-11174	again	_
70-38	11175-11180	using	_
70-39	11181-11182	a	_
70-40	11183-11196	cluster-based	_
70-41	11197-11208	permutation	_
70-42	11209-11217	approach	_
70-43	11218-11220	to	_
70-44	11221-11228	account	_
70-45	11229-11232	for	_
70-46	11233-11241	multiple	_
70-47	11242-11253	comparisons	_
70-48	11254-11255	.	_

Text=fMRI preprocessing Analysis of the fMRI data was conducted in SPM8 (www.fil.ion.ucl.ac.uk/spm).
71-1	11256-11260	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
71-2	11261-11274	preprocessing	_
71-3	11275-11283	Analysis	_
71-4	11284-11286	of	_
71-5	11287-11290	the	_
71-6	11291-11295	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
71-7	11296-11300	data	_
71-8	11301-11304	was	_
71-9	11305-11314	conducted	_
71-10	11315-11317	in	_
71-11	11318-11322	SPM8	_
71-12	11323-11324	(	_
71-13	11325-11350	www.fil.ion.ucl.ac.uk/spm	_
71-14	11351-11352	)	_
71-15	11353-11354	.	_

Text=After discarding the first four images, spikes and other artifacts were detected.
72-1	11355-11360	After	_
72-2	11361-11371	discarding	_
72-3	11372-11375	the	_
72-4	11376-11381	first	_
72-5	11382-11386	four	_
72-6	11387-11393	images	_
72-7	11394-11395	,	_
72-8	11396-11402	spikes	_
72-9	11403-11406	and	_
72-10	11407-11412	other	_
72-11	11413-11422	artifacts	_
72-12	11423-11427	were	_
72-13	11428-11436	detected	_
72-14	11437-11438	.	_

Text=Bad slices (average: 0.5%; range: 0–7.6%) were interpolated from surrounding images using the ArtRepair toolbox.
73-1	11439-11442	Bad	_
73-2	11443-11449	slices	_
73-3	11450-11451	(	_
73-4	11452-11459	average	_
73-5	11460-11461	:	_
73-6	11462-11465	0.5	_
73-7	11466-11467	%	_
73-8	11468-11469	;	_
73-9	11470-11475	range	_
73-10	11476-11477	:	_
73-11	11478-11483	0–7.6	_
73-12	11484-11485	%	_
73-13	11486-11487	)	_
73-14	11488-11492	were	_
73-15	11493-11505	interpolated	_
73-16	11506-11510	from	_
73-17	11511-11522	surrounding	_
73-18	11523-11529	images	_
73-19	11530-11535	using	_
73-20	11536-11539	the	_
73-21	11540-11549	ArtRepair	_
73-22	11550-11557	toolbox	_
73-23	11558-11559	.	_

Text=In each participant, images were then slice-time corrected and realigned to the first image of each run and then to each other.
74-1	11560-11562	In	_
74-2	11563-11567	each	_
74-3	11568-11579	participant	_
74-4	11580-11581	,	_
74-5	11582-11588	images	_
74-6	11589-11593	were	_
74-7	11594-11598	then	_
74-8	11599-11609	slice-time	_
74-9	11610-11619	corrected	_
74-10	11620-11623	and	_
74-11	11624-11633	realigned	_
74-12	11634-11636	to	_
74-13	11637-11640	the	_
74-14	11641-11646	first	_
74-15	11647-11652	image	_
74-16	11653-11655	of	_
74-17	11656-11660	each	_
74-18	11661-11664	run	_
74-19	11665-11668	and	_
74-20	11669-11673	then	_
74-21	11674-11676	to	_
74-22	11677-11681	each	_
74-23	11682-11687	other	_
74-24	11688-11689	.	_

Text=The mean of the functional images was co-registered to the structural images.
75-1	11690-11693	The	_
75-2	11694-11698	mean	_
75-3	11699-11701	of	_
75-4	11702-11705	the	_
75-5	11706-11716	functional	_
75-6	11717-11723	images	_
75-7	11724-11727	was	_
75-8	11728-11741	co-registered	_
75-9	11742-11744	to	_
75-10	11745-11748	the	_
75-11	11749-11759	structural	_
75-12	11760-11766	images	_
75-13	11767-11768	.	_

Text=The structural images were segmented into gray and white matter and the functional images were spatially normalized and then smoothed with a 10 mm FWHM Gaussian kernel.
76-1	11769-11772	The	_
76-2	11773-11783	structural	_
76-3	11784-11790	images	_
76-4	11791-11795	were	_
76-5	11796-11805	segmented	_
76-6	11806-11810	into	_
76-7	11811-11815	gray	_
76-8	11816-11819	and	_
76-9	11820-11825	white	_
76-10	11826-11832	matter	_
76-11	11833-11836	and	_
76-12	11837-11840	the	_
76-13	11841-11851	functional	_
76-14	11852-11858	images	_
76-15	11859-11863	were	_
76-16	11864-11873	spatially	_
76-17	11874-11884	normalized	_
76-18	11885-11888	and	_
76-19	11889-11893	then	_
76-20	11894-11902	smoothed	_
76-21	11903-11907	with	_
76-22	11908-11909	a	_
76-23	11910-11912	10	_
76-24	11913-11915	mm	_
76-25	11916-11920	FWHM	_
76-26	11921-11929	Gaussian	_
76-27	11930-11936	kernel	_
76-28	11937-11938	.	_

Text=The selection of this smoothing kernel was based on a previous semantic priming fMRI in healthy adults; it is appropriate for detecting small effects (such as the masked priming effect) at the group level, while still accommodating anatomical and functional variation between individuals (see for discussion) — a particularly important consideration in schizophrenia (e.g .).
77-1	11939-11942	The	_
77-2	11943-11952	selection	_
77-3	11953-11955	of	_
77-4	11956-11960	this	_
77-5	11961-11970	smoothing	_
77-6	11971-11977	kernel	_
77-7	11978-11981	was	_
77-8	11982-11987	based	_
77-9	11988-11990	on	_
77-10	11991-11992	a	_
77-11	11993-12001	previous	_
77-12	12002-12010	semantic	_
77-13	12011-12018	priming	_
77-14	12019-12023	fMRI	_
77-15	12024-12026	in	_
77-16	12027-12034	healthy	_
77-17	12035-12041	adults	_
77-18	12042-12043	;	_
77-19	12044-12046	it	_
77-20	12047-12049	is	_
77-21	12050-12061	appropriate	_
77-22	12062-12065	for	_
77-23	12066-12075	detecting	_
77-24	12076-12081	small	_
77-25	12082-12089	effects	_
77-26	12090-12091	(	_
77-27	12092-12096	such	_
77-28	12097-12099	as	_
77-29	12100-12103	the	_
77-30	12104-12110	masked	_
77-31	12111-12118	priming	_
77-32	12119-12125	effect	_
77-33	12126-12127	)	_
77-34	12128-12130	at	_
77-35	12131-12134	the	_
77-36	12135-12140	group	_
77-37	12141-12146	level	_
77-38	12147-12148	,	_
77-39	12149-12154	while	_
77-40	12155-12160	still	_
77-41	12161-12174	accommodating	_
77-42	12175-12185	anatomical	_
77-43	12186-12189	and	_
77-44	12190-12200	functional	_
77-45	12201-12210	variation	_
77-46	12211-12218	between	_
77-47	12219-12230	individuals	_
77-48	12231-12232	(	_
77-49	12233-12236	see	_
77-50	12237-12240	for	_
77-51	12241-12251	discussion	_
77-52	12252-12253	)	_
77-53	12254-12255	—	_
77-54	12256-12257	a	_
77-55	12258-12270	particularly	_
77-56	12271-12280	important	_
77-57	12281-12294	consideration	_
77-58	12295-12297	in	_
77-59	12298-12311	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
77-60	12312-12313	(	_
77-61	12314-12317	e.g	_
77-62	12318-12319	.	_
77-63	12320-12321	)	_
77-64	12322-12323	.	_

Text=We next used the Artifact Detection Toolbox (ART,) to calculate the percentage of time points/volumes (across all runs) in which either the composite motion was greater than 1 mm and/or the image intensity was greater than 6 * SD of the mean image intensity of that participant.
78-1	12324-12326	We	_
78-2	12327-12331	next	_
78-3	12332-12336	used	_
78-4	12337-12340	the	_
78-5	12341-12349	Artifact	_
78-6	12350-12359	Detection	_
78-7	12360-12367	Toolbox	_
78-8	12368-12369	(	_
78-9	12370-12373	ART	_
78-10	12374-12375	,	_
78-11	12376-12377	)	_
78-12	12378-12380	to	_
78-13	12381-12390	calculate	_
78-14	12391-12394	the	_
78-15	12395-12405	percentage	_
78-16	12406-12408	of	_
78-17	12409-12413	time	_
78-18	12414-12428	points/volumes	_
78-19	12429-12430	(	_
78-20	12431-12437	across	_
78-21	12438-12441	all	_
78-22	12442-12446	runs	_
78-23	12447-12448	)	_
78-24	12449-12451	in	_
78-25	12452-12457	which	_
78-26	12458-12464	either	_
78-27	12465-12468	the	_
78-28	12469-12478	composite	_
78-29	12479-12485	motion	_
78-30	12486-12489	was	_
78-31	12490-12497	greater	_
78-32	12498-12502	than	_
78-33	12503-12504	1	_
78-34	12505-12507	mm	_
78-35	12508-12514	and/or	_
78-36	12515-12518	the	_
78-37	12519-12524	image	_
78-38	12525-12534	intensity	_
78-39	12535-12538	was	_
78-40	12539-12546	greater	_
78-41	12547-12551	than	_
78-42	12552-12553	6	_
78-43	12554-12555	*	_
78-44	12556-12558	SD	_
78-45	12559-12561	of	_
78-46	12562-12565	the	_
78-47	12566-12570	mean	_
78-48	12571-12576	image	_
78-49	12577-12586	intensity	_
78-50	12587-12589	of	_
78-51	12590-12594	that	_
78-52	12595-12606	participant	_
78-53	12607-12608	.	_

Text=Participants in which more than 20% of volumes met one or both of these two criteria were excluded (as noted above, this resulted in the exclusion of two people with schizophrenia).
79-1	12609-12621	Participants	_
79-2	12622-12624	in	_
79-3	12625-12630	which	_
79-4	12631-12635	more	_
79-5	12636-12640	than	_
79-6	12641-12643	20	_
79-7	12644-12645	%	_
79-8	12646-12648	of	_
79-9	12649-12656	volumes	_
79-10	12657-12660	met	_
79-11	12661-12664	one	_
79-12	12665-12667	or	_
79-13	12668-12672	both	_
79-14	12673-12675	of	_
79-15	12676-12681	these	_
79-16	12682-12685	two	_
79-17	12686-12694	criteria	_
79-18	12695-12699	were	_
79-19	12700-12708	excluded	_
79-20	12709-12710	(	_
79-21	12711-12713	as	_
79-22	12714-12719	noted	_
79-23	12720-12725	above	_
79-24	12726-12727	,	_
79-25	12728-12732	this	_
79-26	12733-12741	resulted	_
79-27	12742-12744	in	_
79-28	12745-12748	the	_
79-29	12749-12758	exclusion	_
79-30	12759-12761	of	_
79-31	12762-12765	two	_
79-32	12766-12772	people	_
79-33	12773-12777	with	_
79-34	12778-12791	schizophrenia	_
79-35	12792-12793	)	_
79-36	12794-12795	.	_

Text=In the remainder of participants, we used the toolbox to create additional regressors that identified any volume that met either or both of the above criteria.
80-1	12796-12798	In	_
80-2	12799-12802	the	_
80-3	12803-12812	remainder	_
80-4	12813-12815	of	_
80-5	12816-12828	participants	_
80-6	12829-12830	,	_
80-7	12831-12833	we	_
80-8	12834-12838	used	_
80-9	12839-12842	the	_
80-10	12843-12850	toolbox	_
80-11	12851-12853	to	_
80-12	12854-12860	create	_
80-13	12861-12871	additional	_
80-14	12872-12882	regressors	_
80-15	12883-12887	that	_
80-16	12888-12898	identified	_
80-17	12899-12902	any	_
80-18	12903-12909	volume	_
80-19	12910-12914	that	_
80-20	12915-12918	met	_
80-21	12919-12925	either	_
80-22	12926-12928	or	_
80-23	12929-12933	both	_
80-24	12934-12936	of	_
80-25	12937-12940	the	_
80-26	12941-12946	above	_
80-27	12947-12955	criteria	_
80-28	12956-12957	.	_

Text=Across these remaining participants, less than 2% of volumes/time points were marked.
81-1	12958-12964	Across	_
81-2	12965-12970	these	_
81-3	12971-12980	remaining	_
81-4	12981-12993	participants	_
81-5	12994-12995	,	_
81-6	12996-13000	less	_
81-7	13001-13005	than	_
81-8	13006-13007	2	_
81-9	13008-13009	%	_
81-10	13010-13012	of	_
81-11	13013-13025	volumes/time	_
81-12	13026-13032	points	_
81-13	13033-13037	were	_
81-14	13038-13044	marked	_
81-15	13045-13046	.	_

Text=At the first level of analysis, each run was modeled with a design matrix that included regressors for each of the three experimental conditions and the two types of filler trials (insect word in the prime and the target position).
82-1	13047-13049	At	_
82-2	13050-13053	the	_
82-3	13054-13059	first	_
82-4	13060-13065	level	_
82-5	13066-13068	of	_
82-6	13069-13077	analysis	_
82-7	13078-13079	,	_
82-8	13080-13084	each	_
82-9	13085-13088	run	_
82-10	13089-13092	was	_
82-11	13093-13100	modeled	_
82-12	13101-13105	with	_
82-13	13106-13107	a	_
82-14	13108-13114	design	_
82-15	13115-13121	matrix	_
82-16	13122-13126	that	_
82-17	13127-13135	included	_
82-18	13136-13146	regressors	_
82-19	13147-13150	for	_
82-20	13151-13155	each	_
82-21	13156-13158	of	_
82-22	13159-13162	the	_
82-23	13163-13168	three	_
82-24	13169-13181	experimental	_
82-25	13182-13192	conditions	_
82-26	13193-13196	and	_
82-27	13197-13200	the	_
82-28	13201-13204	two	_
82-29	13205-13210	types	_
82-30	13211-13213	of	_
82-31	13214-13220	filler	_
82-32	13221-13227	trials	_
82-33	13228-13229	(	_
82-34	13230-13236	insect	_
82-35	13237-13241	word	_
82-36	13242-13244	in	_
82-37	13245-13248	the	_
82-38	13249-13254	prime	_
82-39	13255-13258	and	_
82-40	13259-13262	the	_
82-41	13263-13269	target	_
82-42	13270-13278	position	_
82-43	13279-13280	)	_
82-44	13281-13282	.	_

Text=Trials were modeled from 100 ms before trial onset until the end of the trial (event duration: 1400 ms) and regressors were convolved with a canonical hemodynamic response function.
83-1	13283-13289	Trials	_
83-2	13290-13294	were	_
83-3	13295-13302	modeled	_
83-4	13303-13307	from	_
83-5	13308-13311	100	_
83-6	13312-13314	ms	_
83-7	13315-13321	before	_
83-8	13322-13327	trial	_
83-9	13328-13333	onset	_
83-10	13334-13339	until	_
83-11	13340-13343	the	_
83-12	13344-13347	end	_
83-13	13348-13350	of	_
83-14	13351-13354	the	_
83-15	13355-13360	trial	_
83-16	13361-13362	(	_
83-17	13363-13368	event	_
83-18	13369-13377	duration	_
83-19	13378-13379	:	_
83-20	13380-13384	1400	_
83-21	13385-13387	ms	_
83-22	13388-13389	)	_
83-23	13390-13393	and	_
83-24	13394-13404	regressors	_
83-25	13405-13409	were	_
83-26	13410-13419	convolved	_
83-27	13420-13424	with	_
83-28	13425-13426	a	_
83-29	13427-13436	canonical	_
83-30	13437-13448	hemodynamic	_
83-31	13449-13457	response	_
83-32	13458-13466	function	_
83-33	13467-13468	.	_

Text=The model also included the additional nuisance regressors created using the Artifact Detection Toolbox as described above.
84-1	13469-13472	The	_
84-2	13473-13478	model	_
84-3	13479-13483	also	_
84-4	13484-13492	included	_
84-5	13493-13496	the	_
84-6	13497-13507	additional	_
84-7	13508-13516	nuisance	_
84-8	13517-13527	regressors	_
84-9	13528-13535	created	_
84-10	13536-13541	using	_
84-11	13542-13545	the	_
84-12	13546-13554	Artifact	_
84-13	13555-13564	Detection	_
84-14	13565-13572	Toolbox	_
84-15	13573-13575	as	_
84-16	13576-13585	described	_
84-17	13586-13591	above	_
84-18	13592-13593	.	_

Text=We defined three contrasts to take to the second level: (a) unrelated word-pairs versus implicit baseline, (b) indirectly related word-pairs versus implicit baseline, (c) directly related word-pairs versus implicit baseline.
85-1	13594-13596	We	_
85-2	13597-13604	defined	_
85-3	13605-13610	three	_
85-4	13611-13620	contrasts	_
85-5	13621-13623	to	_
85-6	13624-13628	take	_
85-7	13629-13631	to	_
85-8	13632-13635	the	_
85-9	13636-13642	second	_
85-10	13643-13648	level	_
85-11	13649-13650	:	_
85-12	13651-13652	(	_
85-13	13653-13654	a	_
85-14	13655-13656	)	_
85-15	13657-13666	unrelated	_
85-16	13667-13677	word-pairs	_
85-17	13678-13684	versus	_
85-18	13685-13693	implicit	_
85-19	13694-13702	baseline	_
85-20	13703-13704	,	_
85-21	13705-13706	(	_
85-22	13707-13708	b	_
85-23	13709-13710	)	_
85-24	13711-13721	indirectly	_
85-25	13722-13729	related	_
85-26	13730-13740	word-pairs	_
85-27	13741-13747	versus	_
85-28	13748-13756	implicit	_
85-29	13757-13765	baseline	_
85-30	13766-13767	,	_
85-31	13768-13769	(	_
85-32	13770-13771	c	_
85-33	13772-13773	)	_
85-34	13774-13782	directly	_
85-35	13783-13790	related	_
85-36	13791-13801	word-pairs	_
85-37	13802-13808	versus	_
85-38	13809-13817	implicit	_
85-39	13818-13826	baseline	_
85-40	13827-13828	.	_

Text=fMRI statistical analysis At the group level, our main focus was on two a priori Regions of Interest (ROIs) which we used for small volume correction — bilateral temporal fusiform cortex (temp-fusiform) and the left anterior superior/middle temporal cortex (left ant-S/MTG), see Fig.
86-1	13829-13833	fMRI	_
86-2	13834-13845	statistical	_
86-3	13846-13854	analysis	_
86-4	13855-13857	At	_
86-5	13858-13861	the	_
86-6	13862-13867	group	_
86-7	13868-13873	level	_
86-8	13874-13875	,	_
86-9	13876-13879	our	_
86-10	13880-13884	main	_
86-11	13885-13890	focus	_
86-12	13891-13894	was	_
86-13	13895-13897	on	_
86-14	13898-13901	two	_
86-15	13902-13903	a	_
86-16	13904-13910	priori	_
86-17	13911-13918	Regions	_
86-18	13919-13921	of	_
86-19	13922-13930	Interest	_
86-20	13931-13932	(	_
86-21	13933-13937	ROIs	_
86-22	13938-13939	)	_
86-23	13940-13945	which	_
86-24	13946-13948	we	_
86-25	13949-13953	used	_
86-26	13954-13957	for	_
86-27	13958-13963	small	_
86-28	13964-13970	volume	_
86-29	13971-13981	correction	_
86-30	13982-13983	—	_
86-31	13984-13993	bilateral	_
86-32	13994-14002	temporal	_
86-33	14003-14011	fusiform	_
86-34	14012-14018	cortex	_
86-35	14019-14020	(	_
86-36	14021-14034	temp-fusiform	_
86-37	14035-14036	)	_
86-38	14037-14040	and	_
86-39	14041-14044	the	_
86-40	14045-14049	left	_
86-41	14050-14058	anterior	_
86-42	14059-14074	superior/middle	_
86-43	14075-14083	temporal	_
86-44	14084-14090	cortex	_
86-45	14091-14092	(	_
86-46	14093-14097	left	_
86-47	14098-14107	ant-S/MTG	_
86-48	14108-14109	)	_
86-49	14110-14111	,	_
86-50	14112-14115	see	_
86-51	14116-14119	Fig	_
86-52	14120-14121	.	_

Text=3 for full description.
87-1	14122-14123	3	_
87-2	14124-14127	for	_
87-3	14128-14132	full	_
87-4	14133-14144	description	_
87-5	14145-14146	.	_

Text=We carried out two separate ANOVAs that crossed Group (schizophrenia, control) and Relatedness (indirectly related vs. unrelated, or directly related vs. unrelated) and constructed Statistical Parametric Maps (SPMs) to reveal any voxels that showed a significant Group by Relatedness interaction, (i.e.
88-1	14147-14149	We	_
88-2	14150-14157	carried	_
88-3	14158-14161	out	_
88-4	14162-14165	two	_
88-5	14166-14174	separate	_
88-6	14175-14181	ANOVAs	_
88-7	14182-14186	that	_
88-8	14187-14194	crossed	_
88-9	14195-14200	Group	_
88-10	14201-14202	(	_
88-11	14203-14216	schizophrenia	_
88-12	14217-14218	,	_
88-13	14219-14226	control	_
88-14	14227-14228	)	_
88-15	14229-14232	and	_
88-16	14233-14244	Relatedness	_
88-17	14245-14246	(	_
88-18	14247-14257	indirectly	_
88-19	14258-14265	related	_
88-20	14266-14269	vs.	_
88-21	14270-14279	unrelated	_
88-22	14280-14281	,	_
88-23	14282-14284	or	_
88-24	14285-14293	directly	_
88-25	14294-14301	related	_
88-26	14302-14305	vs.	_
88-27	14306-14315	unrelated	_
88-28	14316-14317	)	_
88-29	14318-14321	and	_
88-30	14322-14333	constructed	_
88-31	14334-14345	Statistical	_
88-32	14346-14356	Parametric	_
88-33	14357-14361	Maps	_
88-34	14362-14363	(	_
88-35	14364-14368	SPMs	_
88-36	14369-14370	)	_
88-37	14371-14373	to	_
88-38	14374-14380	reveal	_
88-39	14381-14384	any	_
88-40	14385-14391	voxels	_
88-41	14392-14396	that	_
88-42	14397-14403	showed	_
88-43	14404-14405	a	_
88-44	14406-14417	significant	_
88-45	14418-14423	Group	_
88-46	14424-14426	by	_
88-47	14427-14438	Relatedness	_
88-48	14439-14450	interaction	_
88-49	14451-14452	,	_
88-50	14453-14454	(	_
88-51	14455-14458	i.e	_
88-52	14459-14460	.	_

Text=a between-group difference in either the indirect priming effect or the direct priming effect).
89-1	14461-14462	a	_
89-2	14463-14476	between-group	_
89-3	14477-14487	difference	_
89-4	14488-14490	in	_
89-5	14491-14497	either	_
89-6	14498-14501	the	_
89-7	14502-14510	indirect	_
89-8	14511-14518	priming	_
89-9	14519-14525	effect	_
89-10	14526-14528	or	_
89-11	14529-14532	the	_
89-12	14533-14539	direct	_
89-13	14540-14547	priming	_
89-14	14548-14554	effect	_
89-15	14555-14556	)	_
89-16	14557-14558	.	_

Text=For these analyses, we set an initial voxel-level threshold of p <0.005 (whole brain), and we inferred significance if the peak voxel within the ROI reached a familywise error-corrected (FWE) threshold of p <0.05 using a small volume correction.
90-1	14559-14562	For	_
90-2	14563-14568	these	_
90-3	14569-14577	analyses	_
90-4	14578-14579	,	_
90-5	14580-14582	we	_
90-6	14583-14586	set	_
90-7	14587-14589	an	_
90-8	14590-14597	initial	_
90-9	14598-14609	voxel-level	_
90-10	14610-14619	threshold	_
90-11	14620-14622	of	_
90-12	14623-14624	p	_
90-13	14625-14626	<	_
90-14	14627-14632	0.005	_
90-15	14633-14634	(	_
90-16	14635-14640	whole	_
90-17	14641-14646	brain	_
90-18	14647-14648	)	_
90-19	14649-14650	,	_
90-20	14651-14654	and	_
90-21	14655-14657	we	_
90-22	14658-14666	inferred	_
90-23	14667-14679	significance	_
90-24	14680-14682	if	_
90-25	14683-14686	the	_
90-26	14687-14691	peak	_
90-27	14692-14697	voxel	_
90-28	14698-14704	within	_
90-29	14705-14708	the	_
90-30	14709-14712	ROI	_
90-31	14713-14720	reached	_
90-32	14721-14722	a	_
90-33	14723-14733	familywise	_
90-34	14734-14749	error-corrected	_
90-35	14750-14751	(	_
90-36	14752-14755	FWE	_
90-37	14756-14757	)	_
90-38	14758-14767	threshold	_
90-39	14768-14770	of	_
90-40	14771-14772	p	_
90-41	14773-14774	<	_
90-42	14775-14779	0.05	_
90-43	14780-14785	using	_
90-44	14786-14787	a	_
90-45	14788-14793	small	_
90-46	14794-14800	volume	_
90-47	14801-14811	correction	_
90-48	14812-14813	.	_

Text=We report the MNI coordinates, z score and p value of this peak.
91-1	14814-14816	We	_
91-2	14817-14823	report	_
91-3	14824-14827	the	_
91-4	14828-14831	MNI	_
91-5	14832-14843	coordinates	_
91-6	14844-14845	,	_
91-7	14846-14847	z	_
91-8	14848-14853	score	_
91-9	14854-14857	and	_
91-10	14858-14859	p	_
91-11	14860-14865	value	_
91-12	14866-14868	of	_
91-13	14869-14873	this	_
91-14	14874-14878	peak	_
91-15	14879-14880	.	_

Text=To follow up any Group by Relatedness interaction, we averaged across all voxels within the ROI that were activated at the p <0.005 whole brain voxel-wise threshold, and we carried out two-tailed t-tests to examine the effect of Relatedness in each group separately.
92-1	14881-14883	To	_
92-2	14884-14890	follow	_
92-3	14891-14893	up	_
92-4	14894-14897	any	_
92-5	14898-14903	Group	_
92-6	14904-14906	by	_
92-7	14907-14918	Relatedness	_
92-8	14919-14930	interaction	_
92-9	14931-14932	,	_
92-10	14933-14935	we	_
92-11	14936-14944	averaged	_
92-12	14945-14951	across	_
92-13	14952-14955	all	_
92-14	14956-14962	voxels	_
92-15	14963-14969	within	_
92-16	14970-14973	the	_
92-17	14974-14977	ROI	_
92-18	14978-14982	that	_
92-19	14983-14987	were	_
92-20	14988-14997	activated	_
92-21	14998-15000	at	_
92-22	15001-15004	the	_
92-23	15005-15006	p	_
92-24	15007-15008	<	_
92-25	15009-15014	0.005	_
92-26	15015-15020	whole	_
92-27	15021-15026	brain	_
92-28	15027-15037	voxel-wise	_
92-29	15038-15047	threshold	_
92-30	15048-15049	,	_
92-31	15050-15053	and	_
92-32	15054-15056	we	_
92-33	15057-15064	carried	_
92-34	15065-15068	out	_
92-35	15069-15079	two-tailed	_
92-36	15080-15087	t-tests	_
92-37	15088-15090	to	_
92-38	15091-15098	examine	_
92-39	15099-15102	the	_
92-40	15103-15109	effect	_
92-41	15110-15112	of	_
92-42	15113-15124	Relatedness	_
92-43	15125-15127	in	_
92-44	15128-15132	each	_
92-45	15133-15138	group	_
92-46	15139-15149	separately	_
92-47	15150-15151	.	_

Text=In addition to these a priori analyses, we also carried out exploratory whole brain analyses.
93-1	15152-15154	In	_
93-2	15155-15163	addition	_
93-3	15164-15166	to	_
93-4	15167-15172	these	_
93-5	15173-15174	a	_
93-6	15175-15181	priori	_
93-7	15182-15190	analyses	_
93-8	15191-15192	,	_
93-9	15193-15195	we	_
93-10	15196-15200	also	_
93-11	15201-15208	carried	_
93-12	15209-15212	out	_
93-13	15213-15224	exploratory	_
93-14	15225-15230	whole	_
93-15	15231-15236	brain	_
93-16	15237-15245	analyses	_
93-17	15246-15247	.	_

Text=First, we examined the direct and indirect priming effects in the schizophrenia and the control groups separately.
94-1	15248-15253	First	_
94-2	15254-15255	,	_
94-3	15256-15258	we	_
94-4	15259-15267	examined	_
94-5	15268-15271	the	_
94-6	15272-15278	direct	_
94-7	15279-15282	and	_
94-8	15283-15291	indirect	_
94-9	15292-15299	priming	_
94-10	15300-15307	effects	_
94-11	15308-15310	in	_
94-12	15311-15314	the	_
94-13	15315-15328	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
94-14	15329-15332	and	_
94-15	15333-15336	the	_
94-16	15337-15344	control	_
94-17	15345-15351	groups	_
94-18	15352-15362	separately	_
94-19	15363-15364	.	_

Text=Second, we compared the contrast between all word-pairs and the implicit baseline between the schizophrenia and the control groups.
95-1	15365-15371	Second	_
95-2	15372-15373	,	_
95-3	15374-15376	we	_
95-4	15377-15385	compared	_
95-5	15386-15389	the	_
95-6	15390-15398	contrast	_
95-7	15399-15406	between	_
95-8	15407-15410	all	_
95-9	15411-15421	word-pairs	_
95-10	15422-15425	and	_
95-11	15426-15429	the	_
95-12	15430-15438	implicit	_
95-13	15439-15447	baseline	_
95-14	15448-15455	between	_
95-15	15456-15459	the	_
95-16	15460-15473	schizophrenia	_
95-17	15474-15477	and	_
95-18	15478-15481	the	_
95-19	15482-15489	control	_
95-20	15490-15496	groups	_
95-21	15497-15498	.	_

Text=In these exploratory whole brain analyses, we used a liberal initial voxel-level threshold of p <0.05.
96-1	15499-15501	In	_
96-2	15502-15507	these	_
96-3	15508-15519	exploratory	_
96-4	15520-15525	whole	_
96-5	15526-15531	brain	_
96-6	15532-15540	analyses	_
96-7	15541-15542	,	_
96-8	15543-15545	we	_
96-9	15546-15550	used	_
96-10	15551-15552	a	_
96-11	15553-15560	liberal	_
96-12	15561-15568	initial	_
96-13	15569-15580	voxel-level	_
96-14	15581-15590	threshold	_
96-15	15591-15593	of	_
96-16	15594-15595	p	_
96-17	15596-15597	<	_
96-18	15598-15602	0.05	_
96-19	15603-15604	.	_

Text=This is because their main purpose was to determine whether there were any other regions that were modulated outside our regions of interest, even at a liberal threshold.
97-1	15605-15609	This	_
97-2	15610-15612	is	_
97-3	15613-15620	because	_
97-4	15621-15626	their	_
97-5	15627-15631	main	_
97-6	15632-15639	purpose	_
97-7	15640-15643	was	_
97-8	15644-15646	to	_
97-9	15647-15656	determine	_
97-10	15657-15664	whether	_
97-11	15665-15670	there	_
97-12	15671-15675	were	_
97-13	15676-15679	any	_
97-14	15680-15685	other	_
97-15	15686-15693	regions	_
97-16	15694-15698	that	_
97-17	15699-15703	were	_
97-18	15704-15713	modulated	_
97-19	15714-15721	outside	_
97-20	15722-15725	our	_
97-21	15726-15733	regions	_
97-22	15734-15736	of	_
97-23	15737-15745	interest	_
97-24	15746-15747	,	_
97-25	15748-15752	even	_
97-26	15753-15755	at	_
97-27	15756-15757	a	_
97-28	15758-15765	liberal	_
97-29	15766-15775	threshold	_
97-30	15776-15777	.	_

Text=We report any cluster that was significant at a cluster-level FWE-corrected threshold of p <0.05.
98-1	15778-15780	We	_
98-2	15781-15787	report	_
98-3	15788-15791	any	_
98-4	15792-15799	cluster	_
98-5	15800-15804	that	_
98-6	15805-15808	was	_
98-7	15809-15820	significant	_
98-8	15821-15823	at	_
98-9	15824-15825	a	_
98-10	15826-15839	cluster-level	_
98-11	15840-15853	FWE-corrected	_
98-12	15854-15863	threshold	_
98-13	15864-15866	of	_
98-14	15867-15868	p	_
98-15	15869-15870	<	_
98-16	15871-15875	0.05	_
98-17	15876-15877	.	_

Text=We report the size and the p value of the cluster (as a whole) as well as the z scores and uncorrected p values of the individual peaks within that cluster.
99-1	15878-15880	We	_
99-2	15881-15887	report	_
99-3	15888-15891	the	_
99-4	15892-15896	size	_
99-5	15897-15900	and	_
99-6	15901-15904	the	_
99-7	15905-15906	p	_
99-8	15907-15912	value	_
99-9	15913-15915	of	_
99-10	15916-15919	the	_
99-11	15920-15927	cluster	_
99-12	15928-15929	(	_
99-13	15930-15932	as	_
99-14	15933-15934	a	_
99-15	15935-15940	whole	_
99-16	15941-15942	)	_
99-17	15943-15945	as	_
99-18	15946-15950	well	_
99-19	15951-15953	as	_
99-20	15954-15957	the	_
99-21	15958-15959	z	_
99-22	15960-15966	scores	_
99-23	15967-15970	and	_
99-24	15971-15982	uncorrected	_
99-25	15983-15984	p	_
99-26	15985-15991	values	_
99-27	15992-15994	of	_
99-28	15995-15998	the	_
99-29	15999-16009	individual	_
99-30	16010-16015	peaks	_
99-31	16016-16022	within	_
99-32	16023-16027	that	_
99-33	16028-16035	cluster	_
99-34	16036-16037	.	_

Text=All coordinates reported are in MNI space.
100-1	16038-16041	All	_
100-2	16042-16053	coordinates	_
100-3	16054-16062	reported	_
100-4	16063-16066	are	_
100-5	16067-16069	in	_
100-6	16070-16073	MNI	_
100-7	16074-16079	space	_
100-8	16080-16081	.	_

